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1. INTRODUCTION  
In the last four decades the chemistry of 2(5H)-
furanones (also referred as 2-butenolides) has received 
great interest and has experienced a remarkable expansion 
as evidenced by numeous reviews [1–18]. This interest is 
largely justified by the fact that these heterocycles include 
biologically active natural compounds and substances 
possessing interesting biological properties such as 
mutagenic, cytotoxic, anti-inflammatory, fungicidal and 
antibacterial activities. Furthermore, intense research has 
been conducted on the synthesis of brominated 2(5H)-
furanone derivatives as some compounds of this class have 
been found capable to block the bacterial quorum sensing 
(QS), i.e. the cell-to-cell communication of bacteria that 
include antibiotic resistant species [19,20], enhancing 
bacterial clearance [21] and preventing swarming motility 
[22] and the production of QS-regulated virulence factors, 
notably biofilm formation [22–26]. 
However, no updated review regarding a comprehensive 
description of the syntheses of natural and unnatural 
brominated 2(5H)-furanone derivatives and the biological 
properties associated to some of these heterocyclic 
compounds has been published so far. Only two reviews, 
which were published in 2004 and 2011 respectively, deal 
with the synthetic aspects of 3,4-dibromo-5-hydroxy-
2(5H)-furanone (mucobromic acid) (1) [10,14] and 3,4-
dibromo-2(5H)-furanone (2) (Figure 1)[14]. 
 
 
Figure 1. Structures of compounds 1 and 2 
 
 This review with 263 references aims to provide a 
thorough insight of the synthesis of 2(5H)-furanones with 
bromine atoms on the heterocyclic ring and/or brominated 
substituents that include natural products and unnatural 
compounds used in the literature as versatile synthetic 
intermediates. The review also focuses on the biological 
properties of the synthesized compounds with particular 
attention to those of the brominated compounds that have 
been found capable of interfering with the QS system of 
bacteria, especially of those that are cause of mortality and 
morbidity in human beings. The literature data on these 
topics have been organized on the basis of the structures of 
the target compounds and have been subdivided in the 
following sections interposed  between the introduction 
and conclusion: i) synthesis and bioactivity of 2(5H)-
furanone derivatives with one bromine atom on the 
heterocyclic ring; ii) synthesis and bioactivity of 2(5H)-
furanone derivatives with two bromine atoms on the 
heterocyclic ring; iii) synthesis and bioactivity of 2(5H)-
furanone derivatives possessing one bromine atom on the 
heterocyclic ring and monobrominated substituents; iv) 
synthesis and bioactivity of 2(5H)-furanone derivatives 
featuring one bromine atom on the heterocyclic ring and 
dibrominated substituents; v) synthesis and bioactivity of 
2(5H)-furanone derivatives featuring two bromine atoms 
on the heterocyclic ring and brominated substituents; vi) 
synthesis and bioactivity of 2(5H)-furanones with 
monobrominated substituents; and vii) synthesis and 
bioactivity of 2(5H)-furanones with  di-, tri- and tetra-
brominated substituents. 
 The literature has been surveyed from 1951 until the 
end of February 2016. 
 
2. SYNTHESES AND BIOACTIVITY OF 2(5H)-
FURANONE DERIVATIVES WITH ONE BROMINE 
ATOM ON THE HETEROCYCLIC RING  
2.1. SYNTHESIS AND BIOACTIVITY OF 3-BROMO-
2(5H)-FURANONE DERIVATIVES 
In 1979, Reffstrup and Boll investigated the 
bromination reaction of 4-methoxy-2(5H)-furanone (3), a 
commercially available compound, and found that 
treatment of 3 with 1.0 equiv of NBS in CCl4 under reflux 
in the presence of catalytic amount of benzoyl peroxide 
gave a mixture of three brominated compounds which were 
easily separated and identified as 3-bromo-4-methoxy-
2(5H)-furanone (4), 5-bromo-4-methoxy-2(5H)-furanone 
(5) and 3,5-dibromo-4-methoxy-2(5H)-furanone (6) 
(Scheme 1) [27]. Compound 4, which was the main 
component of the mixture, was isolated in 45% yield [27]. 
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Scheme 1. Bromination of compound 3 
 
It is interesting to note that compound 5, which was 
isolated in 9% yield, was used as direct precursor to the 
aglycone 7 (Figure 2) [27] of the antibiotic glycoside 
narthecide, which was isolated from Narthecium 
ossifragrum [28]. 
 
 
Figure 2. Structure of aglycone 7 
 
In 2006, Heo and coworkers synthesized compound 4 in 
80% yield via addition of bromine to 3 and subsequent 
Et3N-mediated elimination of hydrobromic acid (Scheme 
2) [29]. The synthesis was carried out according to a 
protocol described in the literature for the one-pot 
preparation of a-bromoenones from the corresponding 
enones [30]. 
 
 
Scheme 2. High yielding synthesis of 3-bromo-4-
methoxy-2(5H)-furanone (4)  
 
In 2013, Vasamsetty, Khan and Mehta synthesized 3-
bromo-5-methoxy-2(5H)-furanone (11) via a four-step 
protocol in which commercially available furfural (8) was 
the starting material (Scheme 3) [31]. 
 
 
 
Scheme 3. Synthesis of 3-bromo-5-methoxy-2(5H)-
furanone (11) 
 
Thus, Rose Bengal sensitized photo-oxidation of 8 
according to the literature [32] gave 5-hydroxy-2(5H)-
furanone (9) in quantitative yield, which was acetalyzed 
with methanol providing compound 10 in high yield. The 
subsequent bromine addition to 10 through a modified 
literature procedure [33], followed by pyridine-mediated in 
situ dehydrobromination of the resulting compound led to 
11 in 65% yield [31]. 
In 2015, Zhao, Yang, Li and coworkers described that 
3-bromo-2(5H)-furanone (13) could be obtained from 
2(5H)-furanone (12) in 47.6% yield by addition of bromine 
to 12 in Et2O under reflux, followed by Et3N-mediated 
dehydrobromination of the resulting adduct (Scheme 
4)[34]. 
 
 
Scheme 4.  Synthesis of 3-bromo-2(5H)-furanone  (13)  
 
Several years earlier, a similar procedure had been 
employed by de Echagüen and Ortuño for the synthesis of 
3-bromo-5-methyl-2(5H)-furanone (15) from 5-methyl-
2(5H)-furanone (14) (Scheme 5) [35]. However, in this 
case, CCl4 had been used in place of Et2O as the solvent for 
the reaction with bromine. 
 
 
Scheme 5.  Synthesis of compounds 15 and 17 
 
Compound 15 was then employed as the starting 
material for a two-step synthesis of 3-bromo-5-methylene-
2(5H)-furanone (17) involving the AIBN–mediated 
reaction of 15 with 2.7 equiv of NBS in CCl4 under reflux 
and the reductive debromination of the resulting compound 
16 by using zinc dust in THF in the presence of a catalytic 
amount of Cp2TiCl2 (Scheme 5) [35]. 
In 1990, Sánchez-Ferrando and coworkers synthesized a 
1 : 1 mixture of erythro- and threo-3-bromo-5-(1-
hydroxyethyl)-2(5H)-furanone (21) in 20% yield by 
treatment of sorbic acid (18) with 2.62 equiv of NBS in 
water at 37 °C for 18.5 h (Scheme 6) [36]. These authors 
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speculated that the formation of 21 could take place from 
intermediates 19 and 20 (Scheme 6) [36]. 
 
 
 
Scheme 6. Synthesis of 3-bromo-5-(1-hydroxyethyl)-
2(5H)-furanone (21) 
 
In 2006, 3-bromo-5-hydroxy-2(5H)-furanone (23) was 
obtained in 78% yield by Riccio and coworkers via 
photooxidation of 3-bromofuran (22) in CH2Cl2 at – 78 °C 
in the presence of 2 equiv of DBU (Scheme 7) [37].  
 
 
 
Scheme 7.  Synthesis of 3-bromo-5-hydroxy-2(5H)-
furanone (23) 
 
In 2008, 3-bromo-5-methyl-2(5H)-furanone (15) was 
also prepared in 73% yield from ynamine 24 and propylene 
oxide (25) [38] by using the method of Jacobsen [39] as 
shown in Scheme 8. 
 
 
 
Scheme 8.  Synthesis of compound 15 from ynamine 24 
and propylene oxide (25)  
 
Notably, compound 15 was also synthesized in 20-52% 
yield from a-angelica lactone (26) (Figure 3) by 
isomerization and subsequent addition of bromine-
dehydrobromination [40,41].  
 
 
 
Figure 3. Structure of a-angelica lactone (26)  
 
In 2010, Terada and coworkers investigated the axially 
chiral guanidine base (R)-CGB-catalyzed asymmetric 
vinylogous aldol reaction of 3-bromo-2(5H)-furanone (13) 
with benzaldehyde (27) and found that treatment of 13 with 
1.2 equiv of 27 in THF at – 40 °C in the presence of 5 
mol% (R)-CGB led to syn-3-bromo-5-(1-hydroxybenzyl)-
2(5H)-furanone (28) in 42% yield with 98% ee together 
with b,g-unsaturated lactone 29 in 18% yield and 71% ee 
(Scheme 9) [42]. 
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Scheme 9. Synthesis of (R)-3-bromo.5-(1-
hydroxybenzyl)-2(5H)-furanone syn-(28) and lactone 29 
 
In 2000, our research group prepared 3,4-dibromo-
2(5H)-furanone (2) in 75% yield by the reaction of 
mucobromic acid (1) with 1.5 equiv. of NaBH4 in methanol 
at 0 °C for 15 min, followed by the addition of 1.0 equiv of 
concd. sulfuric acid, and found that 2 was able to undergo 
Pd-catalyzed reaction with equimolar amounts of 
aryl(trialkyl)stannanes 30a–e in NMP at room temperature 
to provide regioselectively 4-aryl-3-bromo-2(5H)-
furanones 31a–e in yields ranging from 58 to 76% 
(Scheme 10) [43]. The catalyst system that was used for 
the cross-coupling reactions consisted of 5 mol% 
PdCl2(PhCN)2 and 10 mol% AsPh3 (catalyst A) or was 
obtained by treatment of 2.5 mol% Pd2(dba)3 with 10 
mol% AsPh3 (catalyst B). We also found that compounds 
31 could be used as direct precursors to 3-unsubstituted-4-
aryl-2(5H)-furanones 32 (Figure 4), a class of compounds 
that, in 2001, were synthesized in excellent yields by 
halolactonization of 2,3-allenoic acids followed by a 
Suzuki-type coupling reaction with arylboronic acids [44] 
and, in 2009, were prepared by the reaction of 
diethylphosphonoacetic acid (33) with phenacyl bromides 
34 (Figure 4), followed by an intramolecular Horner-
Emmons type cyclization [45]. 
 
 
 
 
Scheme 10. Synthesis of 3,4-dibromo-2(5H)-furanone 
(2) and its regioselective Pd-catalyzed monoarylation 
reaction with aryl(trialkyl)stannanes 
 
 
Figure 4. Structures of compounds 32–34 
 
In a typical example, we found that treatment of 31c 
with 4.0 equiv of zinc powder, which was activated with 
3.7 mol% 1,2-dibromoethane and then with 3.0 mol% 
Me3SiCl [46] in THF at 65 °C for 89.5 h followed by 
hydrolysis gave 4-(4-methoxyphenyl)-2(5H)-furanone 
(32c) in 74% yield (Scheme 11) [43]. It is worth noting 
that compound 32c had previously been employed as a 
precursor to rubrolide C (35) [47], a metabolite of the 
colonial tunicates Ritterella rubra [48] and Synoicum 
blochmanni [49], which was shown to exhibit antibacterial 
activity against Staphylococcus aureous (MIC = 11 
µg/disc) and Bacillus subtilis (MIC = 11 µg/disc) and 
moderate but selective inhibition of protein phosphatases 1 
and 2A [48]. 
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Scheme 11. Synthesis of compound 32c, a precursor to 
rubrolide C (35)  
 
In 2001, we developed an unprecedented, general and 
efficient procedure for the regioselective synthesis of 4-
alkyl-3-bromo-2(5H)-furanones 37 [50]. We found that the 
reaction of 3,4-dibromo-2(5H)-furanone (2) with 1.1 equiv 
of alkylboronic acids 36 in THF under reflux for 18-23 h in 
the presence of 3.0 equiv of Ag2O, 5 mol% PdCl2(MeCN)2 
and 20 mol% AsPh3 proceeded regioselectively providing 
the cross-coupling products 37 in yields ranging from 69 to 
79% (Scheme 12) [50]. Notably, the cross coupling 
reaction appeared suitable to prepare multigram quantities 
of compounds 37 and in all cases examined it did not 
provide any trace of symmetrical 3,4-dialkyl-2(5H)-
furanones [50]. 
 
 
Scheme 12. Regioselective synthesis of 4-alkyl-3-
bromo-2(5H)-furanones 37 
 
One year later, as part of an effort to explore the use of 
3,4-dibromo-2(5H)-furanone (2) for the selective synthesis 
of nostoclides I (38a) and II (38b) (Figure 5), which are a 
pair of cytotoxic compounds produced by a 
cyanobacterium Nostoc sp. [51], we planned to prepare 3-
bromo-4-isopropyl-2(5H)-furanone (37e) (Figure 4) as a 
useful precursor to these natural products [52]. 
 
 
Figure 5.  Structures of compounds 38a, 38b and 37e 
 
Unfortunately, the reaction of 2 with 1.1 equiv of 
isopropylboronic acid under the experimental conditions 
developed to prepare compounds 37a-d [50] did not occur 
at all. Nevertheless, compound 37e could be synthesized in 
74% overall yield by the two-step route shown in Scheme 
13 [52].  
 
 
Scheme 13. Two-step synthesis of 3-bromo-4-
isopropyl-2(5H)-furanone (37e)  
 
Still in 2002, Zhang and coworkers described the 
preparation of 3,4-dibromo-2(5H)-furanone (2) in 57% 
yield by treatment of mucobromic acid (1) with 1.5 equiv 
of sodium triacetoxyborohydride in CHCl3 at 0–5 °C 
followed by addition of acetic acid [53]. Compound 2 was 
then reacted with 2.0 equiv of 4-(methylthio)phenylboronic 
acid (41) in a 1 : 1 mixture of toluene and water at 20–25 
°C for 3 days in the presence of 5 mol% PdCl2(PPh3)2, 5 
mol% BnEt3NCl and 2.67 equiv of CsF producing 3-
bromo-4-(4-methylthiophenyl)-2(5H)-furanone (31b) in 
75-91% yield (Scheme 14). Compound 31b was then used 
as an advanced precursor to Vioxxâ (42) (Scheme 14), an 
anti-inflammatory drug launched by Merck, which, 
however, in 2004, was withdrawn from the market 
worldwide. 
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Scheme 14. Synthesis of compound 31b, an advanced 
precursor to Vioxxâ (42)   
 
In 2014, 4-aryl-3-bromo-2(5H)-furanones 44a–c were 
synthesized in modest yields by Barbosa and coworkers 
through a PdCl2(PhCN)2/AsPh3-catalyzed Suzuki-Miyaura 
reaction of 2 with 4-arylboronic acids 43a–c in THF at 65 
°C in which Ag2O was used as the base (Scheme 15) [54]. 
 
 
Scheme 15. Synthesis of 4-aryl-3-bromo-2(5H)-furanones 
45a–c  
 
More recently, Wang and coworkers developed an 
efficient protocol for the synthesis of 5-alkoxy-4-aryl-3-
bromo-2(5H)-furanones 47 [55]. It involved the 
PdCl2/PPh3-catalyzed desulfitative regioselective arylation 
of 5-alkoxy-3,4-dibromo-2(5H)-furanones 45 with sodium 
arylsulfinates 46 as aryl source (Scheme 16).  The reaction 
was carried out in toluene under reflux using NaHCO3 as 
the base providing compounds 47 in yields ranging from 
62 to 82% [55]. 
 
 
Scheme 16. Synthesis of 5-alkoxy-4-aryl-3-bromo-
2(5H)-furanones 47 
 
Still in 2015, Hu and coworkers demonstrated that 4-
arylmethyl-3-bromo-2(5H)-furanones 49 could be prepared 
in satisfactory yields by reacting 3,4-dibromo-2(5H)-
furanone (2) with 1.2 equiv of potassium 
arylmethyltrifluoroborates 48 in a 1 : 1 mixture of toluene 
and water at 70 °C for 12 h in the presence of 5 mol% 
PdCl2(dppf) and 2.0 equiv of K2CO3 (Scheme 17) [56].  
The potassium arylmethyltrifluoroborates that were not 
commercially available were prepared prepared according 
to a literature procedure [57]. 
 
 
Scheme 17. Regioselective synthesis of 4-arylmethyl-3-
bromo-2(5H)-furanones 49  
 
It deserves to be noted that compound 49a was used as a 
precursor of gymnoascolide (50) (Figure 6) [56], a 
butenolide isolated from the Australian soil ascomycete 
Gymnoascus reessii [58], as well as of eutypoid (51) 
O OHO
Br Br
O O
Br Br
O
Br
O
O
Ph
O
MeS
S
OMe
O
1 2
31b
42
1) NaBH(OAc)3 (1.5 equiv.)
    CHCl3 , 0 - 5 °C
2) AcOH
     (57%)
4-MeSC6H4B(OH)2 (41) (2.0 equiv.)
PdCl2(PPh3)2 (5 mol%)
CsF (2.67 equiv.)
BnEt3NCl (5 mol%)
PhMe/H2O (1:1), 20 - 25 °C, 3 d
(75 - 91%)
2 steps
(86.4% yield)
O O
Br Br
+
OMe
B(OH)2R
O
Br
O
OMe
R
2 (1.0 equiv.) 43 a-c
PdCl2(PhCN)2 (5.1 mol%)
AsPh3 (20.1 mol%)
Ag2O (3.0 equiv.)
THF, 65 °C, 24 h
44 a-c
44
44a
44b
44c
R
H
Me
Cl
Yield%
35
37
26
O
Br Br
O
+
R1O SO2Na
O
Br
OR1O
R2
R2
45 (1.0 equiv.) 46 (1.1 equiv.)
47
(19 examples)
PdCl2 (5 mol%)
PPh3 (10 mol%)
NaHCO3 (1.5 equiv.)
PhMe, reflux, 12 h
(62 - 82%)
O
Br Br
O
+ ArCH2BF3K
O
Br
O
Ar
2 (1.0 equiv.) 48  (1.2 equiv.) 49
PdCl2(dppf) (5 mol%)
K2CO3 (2.0 equiv.)
PhMe/H2O
70 °C, 12 h
49
49a
49b
49c
49d
49e
Ar
Ph
4-MeC6H4
3-MeC6H4
4-MeOC6H4
4-ClC6H4
Yield%
68
56
55
60
57
8    Journal Name, 2014, Vol. 0, No. 0 Principle Author et al. 
(Figure 6), a metabolite of the mangrove fungus Eutypa sp. 
(# 424) [59.] 
 
 
Figure 6. Structures of naturally-occurring compounds 
50 and 51 
 
In the same year, Kimura, Satoh and coworkers 
described a three-step synthesis of 3-bromo-4-(2-
phenylethyl)-2(5H)-furanone (57) in which bromomethyl 
p-tolyl sulfoxide (52) was the starting material (Scheme 
18) [60]. 
 
 
Scheme 18. Three-step synthesis of compound 57 
 
The synthesis began with the reaction of 52 with LDA 
in THF at –78 °C and addition of 1-bromo-4-phenylbutan-
2-one (53) to the resulting lithium derivative, followed by 
basification with aqueous NaOH, which gave 1-bromo-3-
hydroxyprop-1-enyl p-tolyl sulfoxide (54) in 91% yield. 
The subsequent reaction of 54 with phenyl chloroformate 
(55) in CHCl3 in the presence of pyridine gave sulfoxide 
56 in 83% yield. Finally, the nucleophilic cyclization of the 
magnesium alkylidene carbenoid generated from 56 and i-
PrMgCl·LiCl (57) provided compound 58 in 46% yield 
(Scheme 18) [60]. 
Six years earlier, as part of a study on the synthesis of 
brominated furanones, which are quorum quenching 
compounds that inhibit biofilm formation and the 
expression of virulence in in vitro and in vivo models, 
Kumar and coworkers had synthesized 3-bromo-5-(2-
methylpropylidene)-2(5H)-furanone (64a) and 3-bromo-5-
(2,2-dimethylpropylidene)-2(5H)-furanone (64b) via a 
multi-step route in which 2-pentanones 59a and 59b, 
respectively, were used as starting materials (Scheme 19) 
[61]. The first step of the developed protocol involved the 
regioselective condensation of ketones 59a and 59b with 
glyoxylic acid (60). Addition of bromine to the resulting 
compounds 61a and 61b, respectively, provided the 
dibromo derivatives 62a and 62b, respectively, which 
underwent dehydration by treatment with P2O5 leading to 
3,4-dibromodihydrofuran-2-ones 63a and 63b, 
respectively, which unfortunately proved to be difficult to 
isolate and purify. 
 
 
Scheme 19. Regioselective synthesis of 3-bromo-2(5H)-
furanones 64a and 64b  
 
Therefore, these crude products were reacted with DBU 
in CHCl3 at – 78 °C to give the target compounds 64a and 
64b in 29.5% and 26.6% overall yield, respectively, based 
on the starting ketones 59a and 59b, respectively [61]. The 
biological activity of compounds 64a and 64b however 
was not evaluated. 
Over the past 20 years, significant attention has also 
been paid to the synthesis of enantiomerically pure 5-
alkoxy-3-bromo-2(5H)-furanones. In 1995, Chen and 
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coworkers prepared enantiomerically pure 5-(l-
menthyloxy)-3,4-dibromo-2(5H)-furanone (66a) by 
acetalyzation of mucobromic acid (1) with l-menthol (65) 
in the presence of a catalytic amount of concd. sulfuric acid 
(Scheme 20) [62]. Crystallization of the resulting epimeric 
mixture allowed to obtain enantiomerically pure 66a in 
33% yield. The subsequent tandem Michael addition-
elimination reaction of 66a with thiols or amines then 
yielded 5-alkoxy-3-bromo-2(5H)-furanones 67 and 68 
respectively, in good yields with de > 98% (Scheme 20) 
[62]. 
 
 
 
Scheme 20. Synthesis of chiral 5-alkoxy-3-bromo-
2(5H)-furanones 67 and 68 
 
In 1998, Huang and Chen synthesized 5(R)-[(1R,2S,5R)-
(–)-menthyloxy]-3-bromo-2(5H)-furanone (70a) in 46% 
yield with de > 98% by crystallization of an epimeric 
mixture of 5-(l-menthyloxy)-3-bromo-2(5H)-furanone 
(70), which was obtained via addition of bromine to an 
epimeric mixture of 5-(l-menthyloxy)-2(5H)-furanone (69) 
followed by pyridine-mediated elimination of hydrogen 
bromide (Scheme 21) [63]. 
 
 
Scheme 21. Synthesis of 5(R)-[(1R,2S,5R)-(–)-
menthyloxy]-3-bromo-2(5H)-furanone (70a)  
 
In 2009, Li, Shao and coworkers synthesized a series of 
chiral 2,5-disubstituted 1,3,4-thiadiazoles 72 possessing a 
2(5H)-furanone moiety according to the procedure 
depicted in Scheme 22 [64]. Specifically, acetalyzation of 
mucobromic acid (1) with (–)-menthol [63] and (+)-
borneol [65] followed by separation of the resulting 
diastereomers allowed to obtain enantiomerically pure 
compounds 66a and 66b respectively. The subsequent 
tandem Michael addition–elimination reactions of these 
compounds with 2-mercapto-1,3,4-thiadiazoles 71 then 
gave compounds 72a-l in good to excellent yields (Scheme 
22) [64]. 
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Scheme 22. Synthesis of compounds 72 a-l 
 
It was then discovered that all compounds 72a-l 
exhibited anticancer activity against human epitheloid 
cervix carcinoma (HeLa) cells and that compound 72e 
possessed the best inhibitory activity with an IC50 of 0.9 
µM [64]. 
 
In 2013, a series of 5-alkoxy-4-amino-3-bromo-2(5H)-
furanones of general formula 74 which included chiral 
derivatives were synthesized in modest to good yields by 
Fan, Li and coworkers using a one-pot protocol involving 
the regioselective transalkylation of N-methyl tertiary 
amines 73 with 5-alkoxy-3,4-dibromo-2(5H)-furanones 
45a, 66a and 66b [66]. As shown in Scheme 23, the 
reactions generally occurred in CH2Cl2 or DMSO at room 
temperature producing compounds 74a-j in yields ranging 
from 35 to 87% [66]. Notably, compound 74b in which R1 
= menthyl and R2 = Me was found to posses a significant 
anticancer activity against HeLa cell lines (IC50 = 0.19 
µM/L) [66]. 
 
 
Scheme 23. Synthesis of 5-alkoxy-4-amino-3-bromo-
2(5H)-furanones 74a-j  
 
Two years earlier, Cunha and coworkers had reported 
that a variety of 4-amino-3-bromo-2(5H)-furanones of 
general formula 76 could be obtained by treatment of 3,4-
dibromo-2(5H)-furanone (2) with primary and secondary 
amines 75 at room temperature (Scheme 24) [67]. The 
reactions were generally carried out by treatment of 2 with 
2.0 equiv of amines 75 in methanol providing compounds 
76 in yields ranging from 23 to 92% but, in some cases, 
high yields of compounds 76 were obtained by the reaction 
of 2 with 1.0 equiv of 75 and 1.0 equiv of NaHCO3 [67]. 
 
 
Scheme 24. Synthesis of 4-amino-3-bromo-2(5H)-
furanones 76  
 
It was found that para-substituted anilines afforded 
generally better yields of compounds 76 than ortho-
substituted ones and that their reactions occurred in shorter 
times [67]. 
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In 2012, Wang and coworkers synthesized 5-alkoxy-4-
dialkylamino-3-bromo-2(5H)-furanones 74k, 74l and 74m 
in satisfactory yields by regioselective reaction of 3,4-
dibromo-5-menthyloxy-2(5H)-furanone (66a) with diethyl- 
di-n-propyl- and diisopropylamine, respectively, in THF at 
room temperature using KF as the base (Scheme 25, eq. a) 
[68]. 
 
 
 
Scheme 25. Synthesis of 5-alkoxy-4-dialkylamino-3-
bromo-2(5H)-furanones 74k-o  
 
Furthermore, compounds 74n and 74o were prepared in 
61 and 55% yield respectively, by tandem Michael 
addition-elimination reactions of 3,4-dibromo-5-methoxy-
2(5H)-furanone (45a) with diethyl- and di-n-propylamine, 
respectively (Scheme 25, eq. b) [68]. However, the 
reaction between 45a and diisopropylamine in THF at 
room temperature in the presence of KF, unexpectedly, 
gave methyl (E)-2-bromo-4-(diispropylamino)-4-oxobut-2-
enoate (77) in 51% yield (Scheme 26) [68]. 
 
 
Scheme 26. Synthesis of compound 77 from 45a and 
diisopropylamine   
 
Wang and coworkers also investigated the bioactivity of 
compounds 74 on adenocarcinoma human alveolar basal 
epithelial (A549) cells in vitro and found that some of 
these compounds had anticancer activity and that their 
inhibition activity increased with sample concentration. 
Interestingly, menthyloxy and methoxy substituents at 
position 5 had not influence on the inhibition [68]. 
 
One year later, Wang and coworkers synthesized twenty 
three 5-alkoxy-4-amino-3-bromo-2(5H)-furanones 79 
containing aryl rings by treatment of 5-alkoxy-3,4-
dibromo-2(5H)-furanones 45a and 45b with primary 
amines 78 bearing aryl functionality in THF at room 
temperature or 40 °C using KF as the base (Scheme 27) 
[69].  The resulting tandem Michael addition-elimination 
reactions provided compounds 79 in 21–86% yield (mostly 
over 64%) [69]. 
 
 
Scheme 27. Synthesis of 5-alkoxy-4-amino-3-bromo-
2(5H)-furanones 79  
 
In the last two decades, significant attention has also 
been devoted to the synthesis of (Z)-3-bromo-5-ylidene-
2(5H)-furanones 80 (Figure 7). 
 
 
Figure 7. Structure of compounds 80  
 
In 1998, our research group described the synthesis of 
compounds 80a-d via the route outlined in Scheme 28 
[69]. In particular, according to the general procedure 
which we had previously developed for the regioselective 
and stereospecific monoarylation, monoalkynylation and 
monoalkylation of stereodefined 2,3-dibromo-2-alkenoates 
[70–72], stereoisomerically pure compounds 81a and 81b 
were reacted with 1.3 equiv of alkynylzinc chlorides 82a, 
82b and 82c in THF at 0–20 °C in the presence of 5 mol% 
Pd(PPh3)4 to give stereoisomerically pure compounds 83a–
d in yields ranging from 49 to 80%. 
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Scheme 28. Regioselective synthesis of (Z)-3-bromo-5-
ylidene-2(5H)-furanones 80a–d  
 
These ethyl 2-bromo-2-en-4-ynoates were then 
converted into the required compounds 80a-d by 
saponification with 1N LiOH, followed by acidification 
and lactonization of the resulting crude carboxylic acids by 
heating their toluene solution under argon at 110 °C for 
16–24 h in the presence of 5 mol% trans-di(µ-
acetato)bis[o-(di-o-tolylphosphino)benzyl]dipalladium(II) 
(Herrmann’s palladacycle). Compounds 80a, 80b, 80c and 
80d were so obtained in 45, 36, 50 and 25% yield, 
respectively. Notably, compounds 80a–c were obtained 
together with 3–6% of the corresponding 3-bromo-2H-
pyran-2-ones 84a–c, but 80d was obtained together with a 
significant amount of pyranone 84d, which was isolated in 
45% yield. Nevertheless, when the cyclization reaction of 
the crude carboxylic acid derived from 83d was carried out 
in acetone at 20 °C for 6 h in the presence of 20 mol% 
AgNO3 a mixture of 80d and 84d in ca. 79 : 21 ratio was 
obtained from which pure 80d was isolated in 52% yield 
[69]. Compound 80d was then used as direct precursor to 
bovolide (86), a natural compound first found in butter 
[73]. In fact, the reaction of 80d with 1.5 equiv of 
tetramethyltin (85) in NMP at 80 °C for 72 h in the 
presence of 5 mol% PdCl2(PhCN)2, 10 mol% AsPh3 and 10 
mol% CuI gave 86 in 54% yield (Scheme 29) [69]. 
 
 
Scheme 29. Synthesis of bovolide (86)  
 
In 2001, 4-aryl-3-bromo-2(5H)-furanones 31 were 
synthesized by our research group using a novel protocol 
that involved the PdCl2(MeCN)2/AsPh3-catalyzed 
regioselective Suzuki-Miyaura reaction of 3,4-dibromo-
2(5H)-furanone (2) with 1.1 equiv of arylboronic acids (87) 
in THF at 65 °C and 3.0 equiv of Ag2O [74]. Scheme 30 
depicts the synthesis of compounds 31a, 31f and 31g in 
66%, 79% and 61% yield, respectively, according to this 
protocol. 
 
 
Scheme 30. Synthesis of compounds 31a, 31f and 31g 
via regioselective Suzuki-Miyaura reaction  
 
On the other hand, the Stille-type reaction of 2 with 1.1 
equiv of (4-methoxyphenyl)tributyltin (30a) in NMP at 
room temperature in the presence of a Pd2(dba)3/AsPh3 
catalyst system provided regioselectively 3-bromo-4-(4-
methoxyphenyl)-2(5H)-furanone (31c) in 68% yield 
(Scheme 31) [74]. 
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Scheme 31. Synthesis of compounds 31c via a Stille-
type coupling reaction   
 
Compounds 31f and 31c were then used as advanced 
precursors to (Z)-4-aryl-5-(1-arylmethylene)-3-bromo-
2(5H)-furanones 89a and 89b, respectively. In particular, 
31f and 31c were treated with tert-butyldimethylsilyl 
trifluoromethanesulfonate (TBDMSOTf) and 
diisopropylethylamine yielding the corresponding silyl 
ethers that were not isolated, but immediately reacted with 
aldehydes 88a and 88b, respectively. The resulting 
compounds were not isolated, but submitted to reaction 
with DBU providing compounds 89a and 89b in 95% and 
99% yield, respectively (Scheme 32) [74]. 
 
 
Scheme 32. Stereoselective synthesis of (Z)-4-aryl-5-(1-
arylmethylene)-3-bromo-2(5H)-furanones 89a and 89b   
 
In 2012, our protocol [74] was employed by Barbosa, 
Forlani and coworkers to prepare (Z)-4-aryl-5-(1-
arylmethylene)-3-bromo-2(5H)-furanones 90a–k (Figure 
8) in modest to satisfactory yields starting from 3,4-
dibromo-2(5H)-furanone (2) [75]. Notably, all compounds 
90, except 90j, appeared capable to interfere with the 
photosynthetic electron transport chain in the chloroplasts. 
The IC50 values of the most active compounds, 90b and 
90c, were only 1 order of magnitude higher than those of 
commercial herbicides sharing the same mode of action 
[75]. 
 
 
Figure 8. Structures of compounds 90a–k   
 
In 2015, the same research group synthesized 
stereoisomerically pure compounds (Z)-91a and (Z)-91c–j 
and (E)(Z)-91b (Figure 9) by the same procedure used in 
2012 to prepare 90a–k [75]. 
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Figure 9. Structures of compounds (Z)-91a, (Z)-91c–j, 
and (E)(Z)-91b   
 
All these substances were then evaluated for their 
abilities of interfering with the light-driven reduction of 
ferricyanide by isolated spinach chloroplasts and it was 
found that at 10 µM compound (E)(Z)-91b showed the 
highest effectiveness and that compounds (Z)-91c, (Z)-91e 
and (Z)-91g were very active [75]. 
 
In the same year, Barbosa and coworkers also 
investigated the photosynthetic inhibitory activity of 
rubrolide analogues different from compounds 91a–j and 
discovered that (Z)-4-aryl-5-(arylmethylene)-3-bromo-
2(5H)-furanones 91k–s (Figure 10) were capable of 
inhibiting the basal, uncoupled and phosphorylating 
electron transfer [76]. Thus, these compounds acted as 
inhibitors of the Hill reaction, i.e. the light-driven transfer 
of electrons by chloroplasts in photosynthesis that results 
in the cleavage of water molecules and liberation of 
dioxygen [77]. 
 
Figure 10. Structures of compounds 91k–s    
 
In 2013, Ngi, Thibonnet and coworkers developed a 
new route to (Z)-5-[1-(aryl)methylene]-3-bromo-4-
isopropyl-2(5H)-furanones 95 in which 4-methyl-2-
pentynoic acid (92) was the starting material (Scheme 33) 
and used these compounds as precursors to nostoclide 
analogues [78]. 
 
 
 
Scheme 33. Stereoselective synthesis of (Z)-5-[1-
(aryl)methylene]-3-bromo-4-isopropyl-2(5H)-furanones 
95a–f    
 
Specifically, addition of bromine to 92 using a 
previously reported protocol [79] led to compound 93 in 
93% yield. A mixture of 93 and 2.0 equiv of K2CO3 in 
DMF was then stirred in the dark for 15 min and 
subsequently reacted with 2.0 equiv of arylacetylenes 94 
and 0.2 equiv of CuI at 55–60 °C for 4 h under stirring. 
Hydrolysis of the resulting mixtures with an aqueous 
NH4Cl solution provided stereoselectively compounds 
95a–f in yields ranging from 25 to 68% [78]. Attempts 
were also made to convert compounds 95f and 95e into the 
corresponding O-demethylated derivatives 95c and 95d, 
respectively, but the efforts to carry out the demethylation 
reaction with BBr3 or HBr in acetic acid were unsuccessful 
[78]. 
 
In 2015, Barbosa and coworkers synthesized (Z)-5-[1-
(aryl)methylene]-3-bromo-4-phenyl-2(5H)-furanones 97a 
and 97b in 44% and 70% yield, respectively, via aldol 
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condensation of 3-bromo-4-phenyl-2(5H)-furanone (31a) 
with the required aryl aldehydes 96 (Scheme 34) [80]. 
 
 
Scheme 34. Stereoselective synthesis of (Z)-5-[1-
(aryl)methylene]-3-bromo-4-phenyl-2(5H)-furanones 97a 
and 97b   
 
Compounds 97a and 97b, which similarly to 
compounds 91 are analogues of rubrolides, a class of 
natural 2(5H)-furanones from marine invertebrates [81], 
were then assayed for their effect on non-cyclic electron 
transport from water to methylviologen under basal 
phosphorylation and uncoupled conditions and it was 
found that 97a bearing a fluorine atom in the benzylidene 
group showed markedly higher activity than 97b [80]. 
 
Still in 2015, Médebielle and coworkers carried out the 
synthesis of (Z)-4-alkoxy-5-[1(aryl)methylene]-3-bromo-
2(5H)-furanones 102a–g starting from 4-alkoxy-2(5H)-
furanones 98 through the multistep route outlined in 
Scheme 35 [82]. The reaction of compounds 98 with n-
BuLi and aldehydes 99 in THF yielded aldol adducts 100 
which were directly converted to 4-alkoxy-5-[1-
(aryl)methylene]-2(5H)-furanones 101a–g via a two-
step/one-pot sequence involving an esterification reaction 
with trifluoroacetic anhydride and a DBU-mediated  
elimination reaction. Compounds 101a and 101c–g were 
obtained as stereoisomerically pure Z-configured 
stereoisomers, but 101b was obtained as a 96 : 4 mixture of 
Z and E stereoisomers, respectively. A bromine atom was 
then introduced on the C-3 position of compounds 101 by 
treatment with 1.2–1.5 equiv of bromine in the presence of 
pyridine. Purification of the resulting reaction mixtures by 
silica gel chromatography allowed to obtain 
stereoisomerically pure compounds (Z)-102a–g in yields 
ranging from 60 to 91% (Scheme 35) [82]. 
 
 
 
Scheme 35. Synthesis of compounds 101a-g and 102a-g 
 
 
2.2. SYNTHESIS AND BIOACTIVITY OF 4-BROMO-
2(5H)-FURANONE DERIVATIVES 
In 1953, Schenk synthesized 4-bromo-5-methoxy-
2(5H)-furanone (104) in 85% yield by bromination of 5-
methoxy-2(5H)-furanone (103) in benzene at 0 °C (Scheme 
36)[83]. 
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Scheme 36. Synthesis of 4-bromo-5-methoxy-2(5H)-
furanone (104) 
 
In 1996, Martin and coworkers converted compound 
104 into 4-bromo-5-phenylthio-2(5H)-furanone (106) by 
treatment with a large molar excess of thiophenol (105) in 
CH2Cl2 under reflux in the presence of 2.0 equiv of 
BF3×Et2O (Scheme 37) [84]. 
 
 
Scheme 37. Synthesis of 4-bromo-5-phenylthio-2(5H)-
furanone (106) 
 
In 1963, Mabry reported that 4-bromo-2(5H)-furanone 
(108) could be obtained in a very low yield (ca. 3%) by the 
reaction of 2-furoic acid (107) with 2.1 equiv of bromine in 
water at 28–30 °C for 60 min (Scheme 38) [85]. 
 
 
Scheme 38. Synthesis of 4-bromo-2(5H)-furanone (108) 
from 2-furoic acid (107) 
 
Nevertheless, in 1991, compound 108 was prepared by 
Jas in 86% yield on a 30 g scale by treatment of b-tetronic 
acid (2,4-(3H,5H-furandione) (109) with a Vilsmeier 
reagent prepared from oxalyl bromide (110) and DMF 
(Scheme 39) [86]. 
 
 
Scheme 39 Synthesis of 4-bromo-2(5H)-furanone (108) 
from b-tetronic acid (109)    
 
One year earlier, 4-bromo-3-methyl-2(5H)-furanone 
(112) had been synthesized by Svendson and Sydnes in 
67% yield by treatment of 2,2-dibromo-1-
methylcyclopropanecarboxylic acid (111) with 1.55 equiv 
of CF3COOAg in 2,2,2-trifluoroethanol (TFE) under reflux 
for 19 h and chromatographic purification of the resulting 
crude reaction product (Scheme 40) [87]. 
 
 
 
Scheme 40. Synthesis of 4-bromo-3-methyl-2(5H)-
furanone (112) 
 
Again in 1990 Font, Gracia, and de March described an 
elegant method that allowed them to prepare 4-bromo-
2(5H)-furanones 114a and 114b, 4-bromo-5-methylene-
2(5H)-furanone (117a) and 4-bromo-5-isopropylidene-
2(5H)-furanone (117b) in satisfactory yields starting from 
methyl 4-alkyl-2,3-butadienoates 113a and 113b, 
respectively (Scheme 41) [88]. 
 
 
 
Scheme 41. Synthesis of 4-bromo-2(5H)-furanones 
114a,b and 4-bromo-5-ylidene-2(5H)-furanones 117a,b   
 
In particular, the reaction of 113a with NBS in water at 
room temperature gave 114a in 66% yield. On the other 
hand, 114b was obtained in 58% yield by treatment of 
113b with NBS in water at room temperature and heating 
at reflux of a CHCl3 solution of the resulting product in the 
presence of a catalytic amount of p-TsOH. Allylic 
bromination of 114a with NBS under irradiation with an 
incandescent lamp afforded 4,5-dibromo-2(5H)-furanone 
115a in 78% yield, which was converted to 4-bromo-5-
hydroxy-5-methyl-2(5H)-furanone (116a) in 63% yield by 
treatment with a mixture of THF and water. Finally, 
dehydration of 116a with P2O5 in benzene under reflux 
gave 117a in 62% yield. The same reaction sequence was 
then used to prepare 117b from 114b. In fact, allylic 
bromination of 114b gave 115b in 88% yield. Hydrolysis 
of this compound provided 116b in quantitative yield, 
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which was dehydrated with P2O5 in refluxing benzene 
giving rise to 119b in 64% yield [88]. 
 
In 1998, Sydnes and coworkers reinvestigated the 
solvolysis of 2,2-dibromo-1-methylcyclopropane 
carboxylic acid (118a) in TFE in the presence of 
CF3COOAg and found that the reaction in TFE under 
reflux for 24 h in the presence of 1.16 equiv of CF3COOAg 
gave 4-bromo-3-methyl-2(5H)-furanone (112) in 93% 
yield (Scheme 42) [89]. The same reaction conditions were 
then used to prepare 4-bromo-3,5-dimethyl-2(5H)-furanone 
(119) in 54% yield from trans-2,2-dibromo-1,3-
dimethylcyclopropanecarboxylic acid (118b) (Scheme 42) 
[89]. 
 
 
 
Scheme 42. Synthesis of 4-bromo-2(5H)-furanones 112 
and 119 
 
It deserves also to be mentioned that, in the late 1990s 
and early 2000s, a significant contribution to the 
development of efficient and selective methods for the 
synthesis of variously substituted 4-bromo-2(5H)-
furanones was given by the research group of Ma. In 1999, 
this group reported that 5-alkyl-4-bromo-2(5H)-furanones 
114c and 114d could be synthesized in high yields by the 
reaction of allenecarboxylic acids 120a and 120b, 
respectively, with 2.0 equiv of NBS and 1.0 equiv of 
K2CO3 in water at 25 °C (Scheme 43) [90,91]. 
 
 
 
Scheme 43. Synthesis of 5-alkyl-4-bromo-2(5H)-
furanones 114c and 114d fromn allenecarboxylic acids 
120a and 120b, respectively   
 
In the same year, Ma and Wu reported that 4-bromo-
2(5H)-furanones 122a–f could be obtained in high to 
excellent yields by treatment of 2,3-allenoic acids 121a–f 
with 4.0 equiv of CuBr2 in a 2 : 1 mixture of acetone and 
water at 65-70 °C for 2 h (Scheme 44) [92]. 
 
 
 
Scheme 44. Synthesis of 4-bromo-2(5H)-furanones 
122a–f from 2,3-allenoic acids 121a–f   
 
In 2001, Ma and Shi improved their protocol for the 
bromolactonization reaction of 2,3-allenoic acids with NBS 
and found that the reaction of carboxylic acids 123a–f with 
1.1 equiv of NBS and 0.5 equiv of K2CO3 in water at room 
temperature produced 4-bromo-2(5H)-furanones 124a–f in 
yields ranging from 81 to 99% (Scheme 45) [93]. 
 
 
 
Scheme 45. Synthesis of 4-bromo-2(5H)-furanones 
124a–f by bromolactonization of 2,3-allenoic acids 123a–f 
with NBS/K2CO3 in water     
 
Again in 2001, Ma and Wu demonstrated that ethyl 2,3-
allenoates 125, which were the precursors to compounds 
123, could be directly used as substrates of 
bromolactonization reactions with CuBr2 [94]. In 
particular, it was found that compounds 125 with different 
substitution patterns were able to react with 4.0 equiv of 
CuBr2 in a 3 : 2 mixture of EtOH and water at 80–85 °C 
for 12 h to give 4-bromo-2(5H)-furanones 124 in yields 
ranging from 40 to 97%. As shown in Scheme 46, this 
protocol was used for the synthesis of compounds 124g–q 
[94]. 
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Scheme 46. Bromolactonization of ethyl 2,3-allenoates 
125 with CuBr2  
 
Finally, in 2004, Ma and coworkers synthesized 3-alkyl-5-
aryl-4-bromo-5-hydroxy-2(5H)-furanones 128a–d via 
sequential CuBr2-mediated bromolactonization-
hydroxylation of 4-aryl-2,3-allenoic acids 126a–d (Scheme 
47) [95].  
 
 
 
Scheme 47. Synthesis of 3-alkyl-5-aryl-4-bromo-5-
hydroxy-2(5H)-furanones 128a–d 
 
Specifically, the crude 4-bromo-2(5H)-furanones (127), 
which were obtained by CuBr2-mediated 
bromolactonization of compounds 126a–d with 4.0 equiv 
of CuBr2 in a mixture of acetone and water at 65 °C, were 
hydroxylated with dioxygen (1 atm) in the presence of 0.5–
1.0 equiv of LiOAc×2H2O in a mixture of THF and DMF at 
40 °C leading to compounds 128a–d in yields ranging 
from 49 to 77% [95]. 
 
Previously, Lattermann and coworkers had briefly 
described a synthesis of 4-bromo-5-hydroxy-2(5H)-
furanone (130) from furfural (8) without reporting the 
experimental conditions and yields of the employed 
reactions [96]. These authors found that furfural (8) was 
converted to 5-methoxy-2(5H)-furanone (10) by treatment 
with singlet oxygen using methylene blue as sensitizer in 
methanol (Scheme 48). Addition of bromine to a CHCl3 
solution of 10 in the presence of a catalytic amount of 
PBr3, followed by distillation under vacuum of the 
resulting compound with elimination of HBr gas gave 
crystalline 4-bromo-5-methoxy-2(5H)-furanone (129). 
Finally, treatment of this compound with 1% sulfuric acid 
in dioxane under reflux produced compound 130 in a good 
yield (Scheme 48) [96]. 
 
 
Scheme 48. Synthesis of 4-bromo-5-hydroxy-2(5H)-
furanone (130) from furfural (8)    
 
In the past years, studies have also been conducted on 
the synthesis of naturally-occurring 4-bromo-5-hydroxy-3-
(1-hydroxybutyl)-5-methyl-2(5H)-furanone (131), a 
metabolite called bromobeckerelide (Figure 11) that was 
isolated from the marine red alga Beckerella subcostatum 
[95] and was found to exhibit remarkable activity against 
Bacillus subtilis. In fact, 0.5 mg of 131 caused 10 mm 
diameter of inhibitory zone (in the paper disk method) 
[97]. 
 
 
Figure 11. Structure of bromobeckerelide (131) 
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In 1989, Jefford and coworkers accomplished the first total 
synthesis of 131 in five steps using 5-methylfurfural (132) 
as the starting material (Scheme 49) [98]. In this synthesis, 
for which the various steps were also briefly described by 
Jefford in 1993 [99], bromination of 132 under AlCl3 
catalysis gave 4-bromo-5-methylfurfural (133) in 80% 
yield.  
 
 
 
Scheme 49. Total synthesis of bromobeckerelide (131) 
starting from 5-methylfurfural (132)    
 
Bayer-Villiger oxidation of 133 gave lactone 134, which 
was converted to a boron furanolate (135). The reaction of 
this crude compound with butanal (136) at – 78 °C 
generated 4-bromo-3-(1-hydroxybutyl)-5-methyl-2(5H)-
furanone (137) in 85% yield. Reduction of 137 with 
LiAlH4 in a mixture of Et2O and i-PrOH at – 50 °C or with 
DIBAH in THF at – 20 °C gave furan 138 in 71% yield. 
Finally, smooth oxidation of 138 with magnesium 
monoperoxyphthalate (MMPP) in a mixture of i-PrOH and 
water [96] (or with m-chloroperbenzoic acid [97]) gave 
racemic bromobeckerelide (132) (Scheme 49) [98]. 
 
In 1993, bromobeckerelide (131) was synthesized by 
Katsumura, Ichikawa and Mori by photosensitized 
oxidation of the trisubstituted a-trialkylsilylfuran 139 
(Figure 12), which was obtained by introduction of the 
required substituents into the furan ring via regioselective 
lithiation [100]. 
 
 
 
Figure 12. Structure of the trisubstituted a-
trialkylsilylfuran 139 
 
Two years later, de March, Font and coworkers 
described a new synthesis of bromobeckerelide in which 
the target compound was obtained via a four-step route 
involving the use of methyl 2-butyl-2,3-pentadienoate 
(140) as the starting material (Scheme 50) [101]. 
 
 
 
Scheme 50. Synthesis of bromobeckerelide (131) 
starting from methyl 2,3-allenoate 140      
 
In particular, the light protected reaction of 140 with 1.1 
equiv of NBS in water at 25 °C gave 4-bromo-3-butyl-5-
methyl-2(5H)-furanone (141) in 79% yield. A mixture of 
141 and 2.37 equiv of NBS in CCl4 was subsequently 
irradiated with a 500 W incandescent lamp at 40–45 °C 
and the resulting reaction mixture was filtered and 
concentrated and the residue was treated with a mixture 
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THF and water at room temperature providing pure 4-
bromo-3-(1-bromobutyl)-5-hydroxy-5-methyl-2(5H)-
furanone (142) in 41% yield. The final step of this route 
leading to 131 in 27% yield consisted of a light-protected 
reaction of 142 with 1.27 equiv of AgNO3 in a mixture of 
THF and water for 2 d at room temperature, followed by 
TLC purification of the resulting product (Scheme 50) 
[101]. 
 
In 2004, Brückner and coworkers developed a 
regioselective route to (Z)-4-bromo-5-(trans-2-phenyl-2-
propenylidene)-2(5H)-furanone (147) and (Z)-4-bromo-5-
[1-phenyl(nethylene)]-2(5H)-furanone (149) that involved 
the use of levulinic acid (143) as the starting material 
(Scheme 51) [102]. Specifically, 3.5-dibromolevulinic acid 
(144) was prepared by bromination of 143 according to a 
protocol developed in 1997 by Read and coworkers [103]. 
The subsequent reaction of 144 with concd. sulfuric acid 
gave (Z)-4-bromo-5-(bromomethylene)-2(5H)-furanone 
(145) (C-30) in 41% yield. A Pd(dba)2/AsPh3-catalyzed 
Stille-type cross-coupling reaction between 145 and (E)-2-
phenylethenyltributyltin (146) then produced compound 
147 in 52% yield. On the other hand, a Pd(dba)2/AsPh3-
catalyzed Stille-type reaction of 145 with phenyltributyltin 
(30b) in THF at 65 °C for 9 h gave compound 148 in 47% 
yield (Scheme 51) [102] 
 
 
Scheme 51. Regioselective synthesis of compounds 147 
and 148     
 
In 2009, Kumar and coworkers reported that (Z)-4-
bromo-5-(2-methylpropylidene)-2(5H)-furanone (151a) 
and (Z)-4-bromo-5-(2,2-dimethylpropylidene)-2(5H)-
furanone (151b) were available in 54 and 25% yield, 
respectively, by acid-promoted cyclization of 
dibromocarboxylic acids 149a and 149b, respectively 
(Scheme 52) [61]. The cyclization reaction was postulated 
to proceed via dehydration of the intermediate (Z)-3-
bromo-4-oxo-2-alkenoic acids (150) [61]. 
 
 
 
Scheme 52. Synthesis of (Z)-4-bromo-5-ylidene-2(5H)-
furanones 151a,b 
 
In the same year, Laschat and coworkers described an 
efficient synthesis of an 80 : 20 diastereomeric mixture of 
(5R)- and (5S)-4-bromo-3-methyl-5-[(1R,3R,5R)-1,3,5-
trimethyloctyl]-2(5H)-furanone, (155a) and (155b), 
respectively [104], starting from the known preengland 
wax-derived methyl (2E,4R,6R,8R)-2,4,6,8-
tetramethylundec-2-enaote (152) (Scheme 53) [105]. 
Compound 152 was submitted to ozonolysis with reductive 
work-up with PPh3 according to the method of Herber and 
Breit [106] providing aldehyde 153 in 75% yield. 
Compound 153 was then reacted with (E)-3-
bromomethacrylic acid (154) in the presence of n-BuLi in 
THF at –78°C according to the procedure of Williams and 
coworkers [107] yielding an 80 : 20 diastereomeric mixture 
of compounds 155a and 155b, which were separated by 
chromatography and isolated in 54% and 14% yield, 
respectively. Compound 155b was then used as direct 
precursor to (+)-capensifuranone (156) [104], the 
enantiomer of a compound that, in 1995, was isolated from 
Siphonaria capensis, a genus of cur-breathing sea snails 
from the South-East coast of South Africa [108]. In fact, 
the reaction of 155b with 5.0 equiv of dimethylzinc in a 
mixture of toluene and THF at 0 °C in the presence of 10 
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mol% Pd(PPh3)4 gave 156 in 88% yield (Scheme 53) 
[104]. 
 
 
 
Scheme 53. Synthesis of 4-bromo-2(5H)-furanones 
155a and 155b and (+)-capensifuranone (156) 
 
In 2010, De Keersmaecker and coworkers synthesized 
4-bromo-3-hexyl-5-methylene-2(5H)-furanone (159) in 
12% yield by using a three-step protocol in which n-
hexylmaleic anhydride (157) was the starting material 
(Scheme 54) [109]. In particular, the reaction of 157 with 
1.1 equiv of methylmagnesium iodide in Et2O at –20 °C  
and then at room temperature gave regiospecifically 
compound 158 in 50% yield. The subsequent addition of 
bromine to 158 followed by dehydration and 
dehydrobromination with pyridine in CHCl3 at room 
temperature gave compound 159 in 24% yield. Notably, 
this compound was found capable to inhibit Salmonella 
typhimurium strain ATCC14028 biofilm formation by 50% 
at a concentration of 100-250 µM. In addition, it was also 
found able to inhibit the QS regulated bioluminescence of 
Vibrio harveyi BB120 with an IC50 of 1.357 µM [109]. 
 
 
 
Scheme 54. Synthesis of 4-bromo-3-hexyl-5-
methylene-2(5H)-furanone (159)   
 
2.3. SYNTHESIS OF 5-BROMO-2(5H)-FURANONE 
DERIVATIVES 
In 1952, racemic 5-bromo-2(5H)-furanone (161) was 
synthesized in 81% yield by the reaction of 2-acetoxyfuran 
(160) with an equimolar amount of bromine in CCl4 at –5 ~ 
–10 °C followed by distillation of the resulting low boiling 
products (Scheme 55) [110]. 
 
 
 
Scheme 55. Synthesis of racemic 5-bromo-2(5H)-
furanone (161) from 2-acetoxyfuran (160)  
 
In 1973, compound 161 was prepared in 91% yield by 
treatment of 5-hydroxy-2(5H)-furanone (162) with 1.03 
equiv of pyrocatechol phosphorous tribromide in CH2Cl2 
under reflux for 1.8 h in the presence of molecular sieves 
(Scheme 56) [111]. 
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Scheme 56. Synthesis of racemic 5-bromo-2(5H)-
furanone (161) from 5-hydroxy-2(5H)-furanone (162)     
 
On the other hand, 5-bromo-4-ethyl-3-methyl-2(5H)-
furanone (164) was obtained in quantitative yield by 
treatment of 4-ethyl-3-methyl-5-hydroxy-2(5H)-furanone 
(163) with glacial acetic acid containing HBr gas (40% by 
weight) for 5 d at room temperature (Scheme 57) [111]. 
 
 
 
Scheme 57. Synthesis of 5-bromo-4-ethyl-3-methyl-
2(5H)-furanone (164)      
 
In 1965, 5-bromo-4-phenyl-2(5H)-furanone (166) and 
5-bromo-3-methyl-4-phenyl-2(5H)-furanone (168) were 
synthesized in 60.9% and 98.2% yield, respectively, by 
treatment of the corresponding 5-unsubstituted 2(5H)-
furanones 165 and 167, respectively, with 1.02–1.05 equiv 
of NBS in CCl4 under reflux (Scheme 58, eqs. a and b) 
[112]. The bromination reaction of 165, unlike that of 167, 
was carried out in the presence of a catalytic amount of 
AIBN. It was also described that the reaction of 3,4-
dimethyl-2(5H)-furanone (169) with 1.0 equiv of NBS in 
CCl4 under reflux gave 5-bromo-3,4-dimethyl-2(5H)-
furanone (170) (Scheme 58, eq. c) [112]. However, 
unfortunately, the yield of this reaction was not reported. 
 
 
 
Scheme 58. Synthesis of 5-bromo-2(5H)-furanones 166, 
168 and 170 
 
In 1976, 5-bromo-4-methyl-2(5H)-furanone (172) was 
prepared in 89% yield by reacting 4-methyl-2(5H)-
furanone (171) with 1.08 equiv of NBS in CCl4 under 
reflux and irradiation with a 100 W lamp (Scheme 59) 
[113]. 
 
Scheme 59. Synthesis of 5-bromo-4-methyl-2(5H)-
furanone (172) 
 
Two years later, Pettit and coworkers described that 
methyl 2-aryl-4-oxobutanoates 174a and 174b, which were 
prepared via a multi-step sequence from the corresponding 
arylacetic acids 173a and 173b respectively, underwent 
reaction with an equimolar amount of bromine in glacial 
acetic acid to produce 3-aryl-5-bromo-2(5H)-furanones 
175a and 175b in 23% and 27.1% yield, respectively 
(Scheme 60) [114]. 
 
 
Scheme 60. Synthesis of 3-aryl-5-bromo-2(5H)-
furanones 175a and 175b 
 
In 1989, Martin and coworkers described the synthesis 
of 4-alkoxy-2(5H)-furanones 98a–e from b-tetronic acid 
(109) and their conversion to 4-alkoxy-5-bromo-2(5H)-
furanones 176a–e (Scheme 61) [115]. In particular, they 
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found that the reaction of 109 with 3.0 equiv of alcohols in 
the presence of a catalytic amount of p-TsOH, followed by 
removal of water by azeotropic distillation with benzene 
gave compounds 98 in yields ranging from 64 to 91%. 
Subsequent bromination of compounds 98a–e with 1.05 
equiv of NBS in CCl4 at 0 °C under irradiation with a 
mercury high pressure lamp led to compounds 176a–e in 
yields ranging from 25 to 83% (Scheme 61) [115]. 
 
 
 
Scheme 61. Synthesis of 4-alkoxy-5-bromo-2(5H)-
furanones 176a–e     
 
Finally, in concluding this subsection we wish to point 
out that, at the best of our knowledge, bioactivity data of 
2(5H)-furanones featuring only one bromine atom on the 
heterocyclic ring have not been reported in the literature so 
far. 
 
3. SYNTHESIS AND BIOACTIVITY OF 2(5H)-
FURANONE DERIVATIVES WITH TWO BROMINE 
ATOMS ON THE HETEROCYCLIC RING 
 Mucobromic acid (1) is a dibrominated compound 
which can exist in an open-chain and in a ring form called 
3,4-dibromo-5-hydroxy-2(5H)-furanone (Figure 13). 
 
 
 
Figure 13. Chemical structure of mucobromic acid (1)  
 
It is currently commercially available, but in the past 
years it was prepared by the reaction of furfural (8) [116] 
or 2-furoic acid (107) [117] with bromine in boiling water 
(Scheme 62). 
 
 
 
Scheme 62. Synthesis of mucobromic acid (1) from 
furfural (8) or 2-furoic acid (107)   
 
In 1976, compound 1 was identified as a powerful 
inhibitor of tumoral and pancreatic L-asparagine 
synthetases [118] and, in 1994, it was found to be a potent 
bacterial mutagen with mean molar mutagenicity in the 
Salmonella typhimurium (TA100-S9) assay of 5.54 
revertants/mmol [119].  
In 2009, Marcos and coworkers [120] reported that 1, 
which is a by product of water disinfection especially in 
surface water with high amount of bromide [121], is 
genetoxic leading to high levels of DNA breaks. More 
recently, Yang and coworkers found that 1 significantly 
inhibits the growth of two marine diatoms Cylinthroteca 
sp. and Nitzschia closterium and that the effect of this 
compound depends on the dose and diatoms species [120]. 
These authors further demonstrated that 1 is a quorum 
sensing inhibitor against the formation of Cylinthroteca sp. 
biofilms [122]. 
 
3,4-Dibromo-2(5H)-furanone (2) is another 
dibrominated compound the synthesis of which in the past 
years has been the subject of significant attention 
[43,53,23–126]. However, the synthetic procedures which 
date back to before the 1960s [124,125] are low yielding 
and involve the use of commercially unavailable starting 
materials and/or toxic reagents. Nevertheless, as already 
mentioned in subsection 2.1 of this review, in 2002, Zhang 
and coworkers synthesized 2 in 57% yield by reduction of 
mucobromic acid (1) with sodium triacetoxyborohydride in 
CHCl3 followed by addition of acetic acid (Scheme 14) 
[53]. More recently, we prepared 2 in 89% yield on a 
multigram scale by treatment of 1 with 1.5 equiv of NaBH4 
in methanol followed by addition of 1.0 equiv of concd. 
sulfuric acid (Scheme 63) [126]. 
 
Lalonde and Leo had previously found that in the 
Salmonella typhimurium (TA100) assay compound 2 had a 
mean molar mutagenicity value of 1.18 revertants/nmol, 
lower than that of mucobromic acid (1) (5.54 
revertants/nmol) [119]. 
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Scheme 63. Synthesis of 3,4-dibromo-2(5H)-furanone 
(2) via reduction of mucobromic acid (1) with NaBH4    
 
In 2003, 5-allyl-3,4-dibromo-2(5H)-furanones 178a–c 
were synthesized in good yields by Zhang and coworkers 
via indium-mediated reaction of mucobromic acid (1) with 
1.2 equiv of allyl bromides 177a–c in a 1 : 1 mixture of 
THF and water in the presence of 10 mol% NH4Cl 
(Scheme 64) [127]. 
 
 
 
Scheme 64. Synthesis of 5-allyl-3,4-dibromo-2(5H)-
furanones 178a–c 
 
Interestingly, compounds 178a and 178c were also 
prepared in 75% and 41% yield, respectively, by treatment 
of 1 with the required allyl bromides in the presence of  10 
mol% NH4Cl and 1.2 equiv of tin, a metal much less 
expensive than indium, in a 1 : 1 mixture of THF and water 
[127]. 
 
Two years later, Zhang and coworkers described that 
the synthesis of 5-substituted-3,4-dibromo-2(5H)-
furanones of general formula 180 could be accomplished in 
good yields by the reaction of 1 with equimolar amounts of 
active methylene compounds 179 and 5 mol% In(OAc)3 in 
toluene under reflux, with water separation by a Dean-
Stark apparatus (Scheme 65) [128]. Various Lewis acids 
different from In(OAc)3 were tested, but the latter 
compound turned out to be the most efficient catalyst 
[128]. 
 
 
 
Scheme 65. Synthesis of compounds 180a–f   
 
Zhang and coworkers also reported that the Mukaiyama 
aldol reaction of 1 with methyl trimethylsilyl 
dimethylketeneacetal (181) in toluene at –20 °C for 2 h and 
then at room temperature for 16 h in the presence of 10 
mol% ZnCl2, followed by hydrolysis gave compound 182 
in 75% yield (Scheme 66) [129]. 
 
 
 
Scheme 66. Synthesis of compounds 182 and 184   
 
Moreover, they found that an analogous Sc(OTf)3-
catalyzed Mukaiyama aldol reaction between 1 and 1-
phenyl-1-(trimethylsilyloxy)ethylene (183) in Et2O at –20 
°C for 2 h and then at room temperature for 16 h followed 
by hydrolysis produced 5-(benzoylmethyl)-3,4-dibromo-
2(5H)-furanone (184) in 73% yield [129]. 
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In 2007, in continuation of their studies on the selective 
synthesis of 5-substituted 3,4-dihalo-2(5H)-furanones, 
Zhang and coworkers synthesized 5-aryl-3,4-dibromo-
2(5H)-furanones 185 via In(OTf)3-catalyzed Friedel-
Crafts-type reaction between 1.0 equiv of 1 with 1.5 equiv 
of electron-rich arenes in toluene under reflux.[130] This 
protocol allowed the synthesis of compound 185a, 185b 
and 185c in 71%, 82% and 45% yield, respectively 
(Scheme 67) [130]. 
 
 
 
Scheme 67. Synthesis of 5-aryl-3,4-dibromo-2(5H)-
furanones 185a–c   
 
The same research group described that a 5 : 1 syn/anti 
steroisomeric mixture of 3,4-dibromo-5-
[hydroxy(phenyl)methyl]-2(5H)-furanone (187a) was 
available in 87% yield by direct vinylogous aldol reaction 
of 3,4-dibromo-2(5H)-furanone (2) with benzaldehyde 
(127) in methanol at room temperature in the presence of 
0.5 equiv of Et3N (Scheme 68) [131]. 
 
 
 
Scheme 68. Synthesis of 3,4-dibromo-5-
[hydroxy(phenyl)methyl]-2(5H)-furanone (186a)  
 
In 2010, Terada and coworkers reported the first 
enantioselective direct vinylogous reaction of 2 with aryl 
aldehydes [42]. The method, which involved the reaction 
of 2 with 1.2 equiv of aryl aldehydes in a 1 : 1 mixture of 
acetone and THF at –40 °C in the presence of 5 mol% the 
axially chiral guanidine base (R)-Gb, enabled efficient 
access to optically active compounds 186a–f (Scheme 69) 
[42]. 
 
 
 
Scheme 69. Enantioselective synthesis of compounds 
186a–f  
 
These 3,4-dibromo-5-[hydroxy(phenyl)methyl]-2(5H)-
furanones were obtained in high diastereoselectivity with 
excellent enantioselectivity for the major syn-stereoisomers 
[42]. 
 
In 2012, W.-M. Chen and coworkers synthesized 
stereoisomeric mixtures of 5-(arylmethylene)-3,4-dibromo-
2(5H)-furanones 188a and 188b in 60% and 61% yield, 
respectively, by treatment of racemic syn/anti mixtures of 
compounds 186a and 186b with concd. sulfuric acid in 
methanol at 76 °C for 8 h (Scheme 70) [132]. 
 
 
 
Scheme 70. Synthesis of 5-(arylmethylene)-3,4-
dibromo-2(5H)-furanones 188a and 188b     
 
These authors also synthesized 3,4-dibromo-5-[(2-
furyl)methylene]-2(5H)-furanone (188c) and 3,4-dibromo-
5-[(2-thienyl)methylene]-2(5H)-furanone (188d) in 39 and 
40.5% yield, respectively, by treatment of 2 with 1.1 equiv 
of the required heteroaryl aldehydes in methanol at room 
temperature in the presence of 10 mol% Et3N, 
concentration of the resulting reaction mixtures and 
washing the residues with 5% HCl (Scheme 71) [132]. 
 
O
BrBr
OHO O
BrBr
OAr
1 (1 equiv.)
ArH (1.5 equiv.)
In (OTf)3 (10 mol%)
PhMe, reflux, 2 - 24 h
185
185
185a
185b
185c
Ar
2,3,4-(MeO)3C6H2
2,3,6-(MeO)3C6H2
2,4,5-(MeO)3C6H2
Yield%
71
82
45
O
BrBr
O
+
O
BrBr
O
OH
PhPhCHO
2 (1.0 equiv.) 27 (1.1 equiv.)
Et3N (0.5 equiv.)
MeOH, rt, 2 h
(70%)
186a 
(syn/anti = 5 :1)
O
BrBr
O O
BrBr
O
Ar
HO
Ph
Ph
NH
NH
N
ArCHO (187) (1.2 equiv.)
(R)-Gb (5 mol%)
Acetone/THF (1:1)
-40 °C, 5 h
MeO
MeO
OMe
OMe
OMe
OMe
186a
186b
186c
186d
186e
186f
ArPh
2-MeC6H4
4-MeC6H4
4-MeOC6H4
1-naphthyl
2-furyl
77
82
95
58
74
79
90:10
91:9
86:14
87:13
94:6
85:15
ee%
syn  anti
98
97
99
97
96
97
84
60
80
80
74
88
186 Ar Yield% d.r.(syn/anti)
2 186a-f
O
BrBr
O
Ar
OH
O
BrBr
O
Ar
H
concd. H2SO4 (2.0 equiv.)
MeOH, 76 °C, 8 h
186a : Ar = Ph 
           (syn/anti = 3:97)
186g : Ar = 4-(NO2)C6H4 
           (syn/anti = 23 : 77)
188a : 60% (Z/E = 10 : 90)
188b : 61% (Z/E = 82 : 18)
26    Journal Name, 2014, Vol. 0, No. 0 Principle Author et al. 
 
 
Scheme 71. Synthesis of compounds 188c and 188d 
from 3,4-dibromo-2(5H)-furanone (2)   
 
They finally synthesized 3,4-dibromo-5-(4-
hydroxyphenyl)methylene]-2(5H)-furanone (188e) in 29% 
yield by the reaction of 2 with 1.2 equiv of 4-
hydroxybenzaldehyde (187) and 20 mol% piperidine in 
methanol under reflux for 1.5 h under nitrogen atmosphere 
and concentration in vacuo of the resulting reaction 
mixture (Scheme 72) [132].  
Notably, compounds 188a and 188c were found capable 
to exhibit remarkable effect of biofilm formation inhibition 
on Pseudomonas aeruginosa [130], a Gram-negative 
opportunistic pathogenic bacterium which colonizes most 
wounds forming biofilms making ineffective the clearance 
by immune defensive systems and antibiotherapy, thus 
causing wounds unhealed [133–135]. 
 
 
 
Scheme 72. Synthesis of compound 188e  
 
In 2011, Ramachandran and Sreekumar carried out the 
synthesis of the 3,4-dibromo-2(5H)-furanone derivatives 2, 
189, 190 and 191 starting from mucobromic acid (1) via 
the one-step reactions depicted in Scheme 73 [136]. They 
also tested the antibacterial activity of these substances 
against Escherichia coli, Proteus vulgaris, Pseudomonas 
aeruginosa, and Staphylococcus aureus and found that all 
synthesized compounds showed comparable activity 
against the Gram-negative bacteria E. coli, P. vulgaris, and 
P. aeruginosa [136]. 
 
 
 
Scheme 73. Synthesis of compounds 2, 189, 190 and 
191 from mucobromic acid (1) 
 
Finally, in 2015, Barbosa and coworkers synthesized 
(Z)-5-(arylmethylene)-3,4-dibromo-2(5H)-furanones 188f–
i and evaluated the photosynthesis inhibition properties of 
these substances [78]. As outlined in Scheme 74, 
compounds 188f–i were obtained in modest to satisfactory 
yields via aldol condensation of 2 with the required aryl 
aldehydes in CH2Cl2 solution in the presence of 
TBDMSOTf and i-Pr2NEt.  
 
 
 
Scheme 74. Synthesis of (Z)-5-(arylmethylene)-3,4-
dibromo-2(5H)-furanones 188f–i     
 
The resulting adducts, which were not isolated, were 
treated with DBU in CH2Cl2 under reflux providing 
compounds 188f, 188g, 188h and 188i in 14, 31, 47, and 
67% yield, respectively. Remarkably, among these 
compounds, 188g bearing the strong electron-withdrawing 
CF3 group showed the highest photosynthesis inhibitory 
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activity and 188f exhibited greater activity than 188h in 
uncoupled electron flux [78]. 
 
4. SYNTHESIS AND BIOACTIVITY OF 2(5H)-
FURANONE DERIVATIVES FEATURING ONE 
BROMINE ATOM ON THE HETEROCYCLIC RING 
AND MONOBROMINATED SUBSTITUENTS      
 
In 1982, 3-bromo-5-bromomethyl-2(5H)-furanone (193) 
was prepared in 8.5% yield by Font and coworkers via 
addition of 1.96 equiv of bromine to a stirred solution of 
1.0 equiv of (E)-2,4-pentadienoic acid (192) and 10.2 equiv 
of NaHCO3 in water at room temperature, followed by 
addition of 16 N sulfuric acid (to pH 2) to the resulting 
reaction mixture (Scheme 75) [137]. 
 
Scheme 75. Synthesis of 3-bromo-5-bromomethyl-
2(5H)-furanone (193)     
 
The same authors also synthesized 5-bromo-5-
bromomethyl-2(5H)-furanone (195) in 54% yield by 
treatment of 5-bromomethyl-2(5H)-furanone (194) with 
NBS in CH2Cl2 at room temperature for 4 h (Scheme 76) 
[137]. 
 
 
 
Scheme 76. Synthesis of 5-bromo-5-bromomethyl-
2(5H)-furanone (195)       
 
In 1979, Beechan and Sims concisely described the first 
total synthesis of (Z)-4-bromo-5-(bromomethylene)-3-
butyl-2(5H)-furanone (196) (Figure 14) [138], a naturally 
occurring fimbrolide isolated from the marine red alga 
Delisea pulchra [139–141] and Delisea elegans [142]. 
 
 
 
Figure 14. Structures of compounds 196 and AHLs  
 
The synthesis of this natural compound, which has 
structural similarity to N-acyl homoserine lactones (AHLs) 
(Figure12), the most common quorum sensing (QS) signals 
in Gram-negative bacteria [143], commenced with the 
EtONa-mediated alkylation of ethyl acetoacetate (198) 
with commercially available ethyl 2-bromohexanoate (199) 
in EtOH under reflux (Scheme 77). 
 
 
 
Scheme 77. First total synthesis of natural furanone 196  
 
The reaction gave compound 200 in 45% yield, which 
was converted to g-ketoacid 201 by hydrolysis followed by 
decarboxylation of the resulting unstable dicarboxylic acid. 
Bromination of 201 in CHCl3 solution according to the 
literature [144] gave crude dibromocarboxylic acid 202, 
which on treatment with 40% sulfuric acid at 100 °C 
provided compound 196 in 28% yield based on 201. As 
shown in Scheme 77, compound 196 was obtained together 
with a small amount of (E)-4-bromo-5-(bromomethylene)-
3-butyl-2(5H)-furanone (203) [138], a natural product 
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which was isolated from D. pulchra [57,139] and D. 
elegans [142]. 
 
Another multi-step total synthesis of compound 196 was 
described in 1985 by Caine and Ukuchukvu (Scheme 78) 
[148]. It began with the addition of bromine to methyl 2-
butylpropenoate (204). 
 
 
 
Scheme 78. Total synthesis of compound 196 starting 
from ester 204  
 
The resulting compound was dehydrobrominated by 
treatment with i-PrONa in i-PrOH affording compound 206 
in 50% yield. The latter was converted in high yield to the 
corresponding carboxylic acid 207 by treatment with 
aqueous EtOH at 25 °C for 48 h and removal of EtOH 
followed by acidification with 15% HCl. Compound 207 
was then reacted with 2 equiv of n-BuLi in THF at –78 °C 
and the resulting organolithium derivative was treated with 
1.5 equiv of Ac2O in THF at –78 °C. Acidification of the 
reaction mixture with 15% HCl gave 2(5H)-furanone 208 
in 45% yield, which was reacted with a mixture of P2O5 
and benzene under reflux providing 4-bromo-3-butyl-5-
methylene-2(5H)-furanone (209) in 87% yield. Finally, 
addition of bromine to 209 and dehydration of the resulting 
adduct with DBU in CH2Cl2 at –10 °C, followed by 
acidification with 15% HCl, gave the required compound 
196 in 95% yield and 13.4% overall yield based on ester 
204 (Scheme 78) [148]. 
 
In 1997, Read and coworkers reinvestigated the 
cyclization reaction of crude dibromocarboxylic acid 202 
with 100% sulfuric acid and found that the reaction at 110–
120 °C for 20 min produced five products, compound 196 
(which was erroneously called E-configured), 3-butyl-5-
(dibromomethylene)-2(5H)-furanone (210), 4-bromo-3-
butyl-5-(dibromomethylene)-2(5H)-furanone (211), 5-
(bromomethyl)-3-butyl-4,5-dibromo-2(5H)-furanone (212), 
and 4-bromo-3-butyl-5-(dibromomethyl)-2(5H)-furanone 
(213) in 21%, 17%, 14%, 6%, and 5% yield, respectively 
(Scheme 79)  [103]. 
 
 
 
Scheme 79. Products obtained by cyclization of crude 
202 with 100% sulfuric acid    
 
Read and coworkers also reported that the reaction of 2-
ethyl-4-oxopentanoic acid (214) with 2.2 equiv of bromine 
in CHCl3 at 50 °C, followed by treatment of the resulting 
crude dibromoacid with 100% sulfuric acid at 110–120 °C 
for 20 min gave a mixture of (Z)-4-bromo-5-
(bromomethylene)-3-ethyl-2(5H)-furanone (215), 3-ethyl-
5-(dibromomethylene)-2(5H)-furanone (216) and 4-bromo-
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5-(dibromomethylene)-3-ethyl-2(5H)-furanone (217) from 
which compounds 215, 216 and 217 were isolated in 42%, 
17% and 5% yield, respectively (Scheme 80) [103]. 
 
Scheme 80. Synthesis of compounds 215–217  
 
In 1995 by de March, Font and coworkers described a 
formal total synthesis of (Z)-4-bromo-5-
(bromomethylene)-3-butyl-2(5H)-furanone (196) via a 
route involving the use of 4-bromo-3-butyl-5-methyl-
2(5H)-furanone (141) as a key intermediate (Scheme 81) 
[101]. Compound 141, which was prepared in 79% yield 
by bromination of methyl 2-butyl-2,3-pentadienoate (140) 
with 1.1 equiv of NBS in water at room temperature, was t 
reacted with 1.5 equiv of NBS in CCl4 at 70–75 °C for 130 
h in the presence of a catalytic amount of NaHCO3 
providing a mixture of compounds 141, 218, 219 and 220 
in 9%, 31%, 19% and 17% yield, respectively. Hydrolysis 
of this mixture followed by purification of the resulting 
crude products by flash chromatography allowed to isolate 
4-bromo-3-butyl-5-hydroxy-5-methyl-2(5H)-furanone 
(208) in 26% yield. According to the literature [145] 
compound 208 is an advanced precursor to fimbrolide 196. 
 
In 2009, Janda and coworkers described a further 
synthesis of compound 196 that involved a new interesting 
protocol for the cyclization reaction of dibromocarboxylic 
acid 202 (Scheme 82) [146]. In fact, crude 
dibromocarboxylic acid 202, which was obtained by 
reacting ketoacid 201 with 2.2 equiv of bromine on a 2 : 1 
mixture of AcOH and CHCl3, was reacted with 
fluorosulfonic acid in CH2Cl2 at 0 °C for 1 h and then at 50 
°C for 2 h providing 196 in 33% yield based on 201. 
Notably, this cyclization protocol allowed to overcome the 
many problems related to the execution of the cyclization 
reaction making use of sulfuric acid at 110–120 °C, i.e.  
low yields due to both polymerization and decomposition 
and possible explosion of the reaction content when the 
reaction is carried out upon scale-up [146]. 
 
 
 
 
 
Scheme 81. Formal total synthesis of fimbrolide 196  
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Scheme 82. Synthesis of natural fimbrolide 196 via 
FSO3H-mediated cyclization of crude compound 202    
 
With regard to the bioactivity of 2(5H)-furanone 
derivatives featuring one bromine atom on the heterocyclic 
ring and mononobrominated substituents, it should be 
noted that since the late 1990s several studies have been 
conducted on the biological properties of (Z)-4-bromo-5-
(bromomethylene)-3-butyl-2(5H)-furanone (196). In 1998, 
Kjelleberg and coworkers, in the context of an 
investigation on the role of putative extracellular signal 
molecules in the regulation of the carbon starvation 
response of marine Vibrio sp. strain S14, discovered that 
compound 196 inhibits the synthesis of proteins 
specifically induced upon carbon starvation [147].  
 
In 2000, Givskov and coworkers found that 196 inhibits 
the swarmimg motility of the Gram-negative bacterium 
Serratia liquefaciens MG1 and demonstrated that this 
natural compound controls transcription of the QS 
regulated gene swrA in competition with the cognate signal 
molecule N-butanoyl-L-homoserine lactone (197a, BHL) 
(Figure 15) [148]. 
 
 
 
Figure 15. Structure of N-butanoyl-L-homoserine 
lactone (BHL)  
 
In 2001, Wood and coworkers found that 196 inhibits 
swarming motility of the Gram-negative bacterium 
Escherichia coli at 13 µg/cm2, but does not inhibit its 
growth rate at 13–52 µg/cm2 or from 20 to 100 µg/mL 
[149]. In addition, they demonstrated that 196 is capable to 
inhibit the biofilm formation of E. coli decreasing the 
thickness of the biofilm by 55% at 60 µg/mL and 
descreasing the percentage of live cells by 87%.  
 
In 2002, the same research group reported that 196 
inhibits both the growth of the Gram-positive non-
pathogenic bacterium Bacillus subtilis and its swarming 
motility in a concentration dependent way.[150] This 
research group also found that 196 is able to inhibit the 
biofilm formation of B. subtilis at 40 µg/mL decreasing the 
biofilm formation by 25% and reducing the percentage of 
live cells by 63 % [150].  These results were of significant 
interest since biofilm formation of B. subtilis, which is 
apparently dependent on LuxS- (S-ribosylhomocysteine 
lyase)-based QS by autoinducer 2 (AI-2), represents a 
continuous hygienic problem in the dairy industry and can 
lead to serious economic losses [151]. 
 
In 2004, in order to discover the mechanism of 
inhibition of the growth, swarming and biofilm formation 
in Gram-positive bacteria, Wood and coworkers 
investigated the gene expression profiles of B. subtilis 
grown with and without 5 µg/mL of compound 196 and 
found that this sublethal concentration led to the induction 
of specific genes involved in stress responses, fatty acid 
biosynthesis, lichenan degradation, transport and 
metabolism [152].  
 
In the same year, Ren and Wood demonstrated that 196 
is able to inhibit the mild steel corrosion induced by the 
Gram-positive sulphate-reducing bacterium 
Desulfotomaculum orientis [153]. In particular, they found 
that 20 and 40 µg/mL of 196 inhibited 58% and 96% of the 
D. orientis growth, respectively [153]. 
 
In 1998, Stintzi and coworkers showed that the 
siderophore synthesis in Pseudomonas aeruginosa may be 
regulated by QS [154] and, in 2005, Wood and coworkers 
evidenced the link between QS and siderophore synthesis 
of the Gram-negative pathogenic bacterium Pseudomonas 
putida F1 demonstrating that the QS disrupter 196 was able 
to inhibit the siderophore produced by this bacterium in a 
concentration dependent way, with 57% synthesis 
repressed by 100 µg/mL of 196 [155]. In contrast, 100 
µg/mL of 196 were found to stimulate siderophore 
biosynthesis in the opportunistic human pathogen 
Pseudomonas aeruginosa PA01 about 3.5 fold [155,156]. 
 
Again in 2005, Jones and coworkers ascertained that 
compound 196 is able to reduce the growth of the Gram-
positive bacterium Bacillus anthracis Sterne strain  (the 
etiologic agent of anthrax) in a dose dependent manner 
[157].  In addition, Zang and coworkers reported that 196 
covalently modifies and inactivates in a concentration 
dependent manner LuxS, the enzyme that produces 
autoinducer-2 (AI-2) [158], a signaling molecule that 
mediates inter-species QS among many bacteria [159]. 
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In 2010, in the course of an investigation on the activity 
of brominated furanones on biofilm formation by 
Salmonella typhimurium ATCC 14028, De Keersmaecker 
and coworkers found that 196 is more active than the 
corresponding 3-alkyl-4-bromo-5-(dibromomethylene)-
2(5H)-furanone 211 (Figure 16),[109] a natural product 
isolated fron D. pulchra [139–141] and D. elegans [142]. 
 
Figure 16. Structure of the natural compound 211    
 
Still in 2010, Ren and coworkers demonstrated the 
antifungal activity of naturally-occurring 196 on the Gram-
positive bacterium Candida albicans, a causal agent of 
opportunistic oral and genital infections in humans, and 
found that 3 µg/mL of this furanone upregulates 32 genes 
of the pathogen with functions of stress response, NAPDH 
dehydrogenation and small molecule transport and 
represses 21 genes involved in cell-wall maintainance 
[160]. 
 
The year before, Landmann and coworkers had found 
that 196 is able to enhance the biofilm formation of 
Staphylococcus epidermis strain 1457, S. epidermis strain 
047 and S. aureus at concentrations between 1.25 and 20 
µM, which are 10 to 20% of the minimum inhibitory 
concentration (MIC) and correlate with an increase of 
polysaccharide intracellular adhesion, the major 
staphylococcal biofilms [161]. Notably, free, but not 
surface bound compound 196 was found to be toxic for 
staphylococci and eukaryotic cells to a similar extent, thus 
excluding a therapeutic application of this compound 
[161]. 
 
(Z)-3-(1-Acetoxybutyl)-4-bromo5-(bromomethylene) 
2(5H)-furanone (221) (Figure 17) in another naturally 
occurring fimbrolide, isolated from D. pulchra [139-141] 
and D. elegans [142] that has been the subject of total 
synthesis.  
 
 
Figure 17. Structure of (Z)-3-(1-acetoxybutyl)-4-
bromo-5-(bromomethylene)-2(5H)-furanone (221)   
 
In 1993, Jefford  briefly described a synthesis of 221 
involving the use of 3-bromo-4-(1-hydroxybutyl)-2-
methylfuran (138) (Scheme 83) [99], a compound available 
from 5-methylfurfural (132) according to the reaction 
sequence outlined in Scheme 49 [98]. Acetylation of 138 
followed by double hydroxylation of the resulting acetate 
222 gave 3-(1-acetoxybutyl)-4-bromo-5-hydroxy-5-
methyl-2(5H)-furanone 223 in high yield. 
 
 
 
Scheme 83. Stereoselective synthesis of (Z)-3-(1-
acetoxybutyl)-4-bromo-5-(bromomethylene)-2(5H)-
furanone (221)     
 
The reaction of 223 with 1.0 equiv of P2O5 in benzene 
under reflux led to 3-(1-acetoxybutyl)-4-bromo-5-
methylene-2(5H)-furanone (224) in 73% yield. Finally, 
addition of bromine to this compound, followed by DBU-
mediated deydrobromination of the resulting adduct 
provided compound 221 in 75% yield (Scheme 83) [99]. 
 
In 1995, de March, Font and coworkers described 
another synthesis of fimbrolide 221 (Scheme 84) [101]. 
 
O
Br
O
Br
Br
Me
209
O
Br
O
H
Br
MeAcO
221
OMe CHO
OMe
Br
HO
n-Pr
OMe
Br
AcO
n-Pr
O O
Br
AcO
n-Pr
HO
Me
O
Br
AcO
n-Pr
O
H
H
O
Br
AcO Me
O
H
Br
Rif. 98
132
138
Ac2O
pyridine
(81%)
222
MCPBA
NaHCO3
(94%)
P2O5 (1 equiv.)
PhH, reflux
(73%)
1) Br2
2) DBU 
    (75%)
223
224
221
32    Journal Name, 2014, Vol. 0, No. 0 Principle Author et al. 
 
 
Scheme 84. Synthesis of fimbrolide 221 starting from 
furanone 141  
 
The developed route involved the reaction of 4-bromo-
3-butyl-5-methyl-2(5H)-furanone (141) [101] with 2.4 
equiv of NBS in CCl4 at 40–45 °C under irradiation for 5 h 
and hydrolysis of the resulting product providing 
compound 225 in 76% yield. Treatment of 225 with 1.46 
equiv of AgOAc in glacial acetic acid followed by addition 
of 10% aqueous NaOH until pH 7-8 produced compound 
223 in 62% yield, which was reacted with P2O5 in benzene 
at 70 °C  producing 224 in 73% yield. Finally, addition of 
2.0 equiv of bromine to a CH2Cl2 solution of 24 at –4 °C in 
the presence of a catalytic amount of hydroquinone and the 
subsequent dehydrobromination of the resulting adduct 
with 1.75 equiv of DBU in CH2Cl2 at –15 °C gave 
compound 221 in 75% yield [101]. 
 
As regards the synthesis of naturally-occurring 2(5H)-
furanone derivatives with one bromine atom on the 
heterocyclic ring and monobrominated substituents, it is 
worth noting that, in 2001, in connection with a project 
directed towards the synthesis of natural products and their 
analogues with potential cytotoxic activity against human 
tumor cell lines, our research group developed an efficient 
procedure for the synthesis of rubrolide N, a metabolite 
isolated from the marine ascidian Synoicum blochmanni to 
which the structure 226 (Figure 18) had been assigned by 
Salvá and coworkers [49]. 
 
 
Figure 18. Proposed structure for rubrolide N  
 
The synthesis of compound 225 was carried out by 
using the reaction sequence outlined in Scheme 85 [74].  
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Scheme 85. Stereoselective synthesis of compound 225  
 
3,4-Dibromo-2(5H)-furanone (2) was submitted to a 
Suzuki-Miyaura reaction with 1.1 equiv of arylboronic acid 
227 in THF at 65 °C in the presence of 3.0 equiv of Ag2O, 
0.5 mol% PdCl2(MeCN)2 and 20 mol% AsPh3 providing 4-
aryl-3-bromo-2(5H)-furanone 31f in 78% yield. A CH2Cl2 
solution of 31f was then sequentially treated with 1.2 equiv 
of TBDMSOTf, 3.0 equiv of i-Pr2NEt and 1.0 equiv of 3-
bromo-4-methoxybenzaldehyde (228) at room temperature 
for 2 h and the resulting mixture was reacted with 2.0 
equiv of DBU at 20 °C for 4 h affording selectively 
compound 229 in 87% yield. Finally, the reaction of 229 
with 5.0 equiv of BBr3 in CH2Cl2 at 20 °C for 48 h 
followed by hydrolysis led to a mixture of (Z)-3-bromo-4-
(3-chloro-4-hydroxyphenyl)-5-[1-(1-bromo-4-
methoxyphenyl)methylene]-2(5H)-furanone  (230) and (Z)-
3-bromo-4-(3-chloro-4-hydroxyphenyl)-5-[1-(3-bromo-4-
hydroxyphenyl)methylene]-2(5H)-furanone (226) from 
which compounds 230 and 226 were isolated in 51% and 
47% yield, respectively [74]. However, several NMR 
parameters of compound 226 did not match with those 
reported for the natural product with the structure of 
rubrolide N [49]. 
 
Many other syntheses of unnatural 2(5H)-furanone 
derivatives bearing one bromine atom on the heterocyclic 
ring and monobrominated substituents have been reported 
in the literature. 
 In 1997, as part of a study of the mutagenicity of 
halogen-substituted furanones, LaLonde and coworkers 
synthesized 3-bromo-4-(bromomethyl)-2(5H)-furanone 
(233), 3,5-dibromo-4-(bromomethyl)-2(5H)-furanone 
(234) and 3-bromo-4-(bromomethyl)-5-hydroxy-2(5H)-
furanone (235) using 4-(bromomethyl)-2(5H)-furanone 
(231) or 4-(hydroxymethyl)-2(5H)-furanone (232) as the 
starting material (Scheme 86) [162]. Addition of 4.6 equiv 
of bromine to a CH2Cl2 solution of 231 followed by 
treatment with 0.92 equiv of Et3N provided compound 233 
in only 12% yield. Nevertheless, compound 233 was 
obtained in 27% yield by the reaction of 232 with 3.3 equiv 
of bromine at room temperature for 8 d followed by Et3N-
mediated dehydrobromination. The subsequent reaction of 
233 with 1.0 equiv of NBS in CCl4 under irradiation with 
an incandescent lamp gave compound 234 in 98% yield 
and 94% GC purity. Finally, treatment of 234 with 1.5 
equiv of AgOAc in 10% aqueous acetone for 4 d at room 
temperature gave 235 in 47% yield [162]. 
 
 
 
Scheme 86.  Synthesis of compounds 233, 234 and 235  
 
LaLonde and coworkers also evaluated the mutagenicity 
potency of compounds 233 and 235 in the Ames 
Salmonella typhimurium (TA100) assay and found that the 
mutagenicity value of 235 was 51.0 fold higher than that of 
233, but considerbly smaller than that observed for the H-
by-OH replacement for the dichloride pair 236 and 237 
(Figure 19) [162]. In fact, 237 had a mutagenicity value of 
145 fold higher than that of 236 [162]. 
 
 
 
Figure 19. Structures of compounds 236 and 237   
 
In 2008, Benneche and coworkers carried out the 
synthesis of stereoisomeric mixtures of 3-bromo-5-
(bromomethylene)-2(5H)-furanone 239 by using three 
different protocols (Scheme 87) [163]. The first protocol 
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(Method A) involved the cleavage of the tert-
butyoxycarbonyl group of the a,b-unsaturated ester 238 by 
treatment with trifluoroacetic acid (TFA) and addition of 
bromine to the resulting compound, followed by reaction 
with Et3N in DMF at room temperature. This one-pot 
protocol provided a 11 : 89 mixture of (E)- and (Z)-239 in 
56% yield, from which (Z)-239 was isolated in 50% yield. 
The second protocol (Method B) consisted of treatment of a 
CCl4 solution of 238 with bromine, addition of TFA to the 
resulting product, stirring the mixture at room temperature 
for 2 d, and evaporation of the solvent followed by addition 
of DMF and Et3N at 0 °C. In this way a 60 : 40 mixture of 
(E)- and (Z)-239 was obtained in 10% yield. In the third 
protocol (Method C) compound 238 was reacted with TFA 
in CH2Cl2 at room temperature, the reaction mixture was 
evaporated and treated with bis(2,4,6-
trimethylpyridino)bromine(I) hexafluorophosphate in 
CH2Cl2 at 0 °C and after 2 h reacted with 1M HCl. This 
protocol allowed to obtain a mixture of (E)- and (Z)-239 in 
a 2 : 98 ratio, respectively, from which compound (Z)-239 
was isolated in 48% yield [163]. 
 
 
 
Scheme 87. Synthesis of compounds (E)- and (Z)-239  
 
Notably, (Z)-239, which was a valuable intermediate to 
lissoclinolide (240), a metabolite of the tunicate 
Lissoclinum patella [164], at 60 µM was found to reduce 
significantly bioluminescence in the Gram-negative, 
bioluminescent, marine bacterium Vibrio harveyi BB170 
compared to control without furanone [40]. About this 
result, it must be pointed out that the use of the 
bioluminescence reduction bioassay of Vibrio harveyi 
constitutes a direct method of detecting potentially 
biohazardous materials in water [165]. 
 
 
 
Figure 20. Structure of lissoclinolide (240)  
 
In 2012, Benneche and coworkers reported that a 
mixture of  (E)- and (Z)-239 in a 10 : 90 ratio, respectively, 
was obtained in 40% yield by reacting 4-bromo-5-
methoxyfurfural (241) with 1.3 equiv of oxalyl bromide 
(110) in CH2Cl2 at 0 °C and heating the resulting reaction 
mixture at room temperature for 45 min (Scheme 88) 
[166]. 
 
 
 
Scheme 88. Synthesis of (E)/(Z)-239 from 4-bromo-5-
methoxyfurfural (241) 
 
As mentioned in Section 2.2, in 2004, Brückner and 
coworkers synthesized (Z)-4-bromo-5-(bromomethylene)-
2(5H)-furanone (145) (C-30) in 41% yield by the reaction 
of 3,5-dibromolevulinic acid (144) with concd. sulfuric 
acid at room temperature for 20 min and then at 85 °C for 
0.5 h (Scheme 51) [102]. In the same year, Johansen and 
coworkers prepared (Z)-4-bromo-5-(bromomethylene)-
2(5H)-[2-14C]furanone (247) in five steps in 7.7% overall 
yield starting from bromo[1-14C]acetic acid (242) (Scheme 
89) [167]. Microwave-accelerated condensation of ethyl 
bromo[1-14C]acetate (243) with ethyl acetoacetate (198)  
and acidic hydrolysis of the resulting diester 244 followed 
by decarboxylation by microwave heating gave [1-
14C]levulinic acid 245. Finally, the bromination reaction of 
245 followed by sulfuric acid-mediated cyclization of the 
resulting dibrominated carboxylic acid 246 gave the 
targeted labelled 2(5H)-furanone 247 with a radiochemical 
purity higher than 97% and specific activity of 57 
mCi/mmol [167]. 
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Scheme 89. Synthesis of (Z)-4-bromo-5-
(bromomethylene)-2(5H)-[2-14C]furanone (247)    
 
In the last two decades, the bioactivity of (Z)-4-bromo-
5-(bromomethylene)-2(5H)-furanone (145) (C-30) has 
been the subject of several studies.  
 
In 2004, Wu and coworkers demonstrated that this 
compound interfers with the action of N-acyl homoserine 
lactones by inhibiting in vivo gene expression regulated by 
QS systems in Pseudomonas aeruginosa [21]. 
Furthermore, these authors showed that 145 also exerts 
favourable therapeutic effects in P. aeruginosa lung 
infection in mice [21] reducing the inflammation in vivo. In 
fact, N-(3-oxododecanoyl)homoserine lactone, an 
important QS signal produced by P. aeruginosa, has been 
shown to have inflammatory effects [168]. 
 
In 2010. Roques and coworkers found that 145 is able to 
inhibit the growth and to restrict the number of adherent P. 
aeruginosa cells when added from the early stages of 
biofilm formation (i.e. adhesion and microcolony 
formation) in a dose dependent way [169]. 
 
In 2013, Defoirdt and coworkers demonstrated that the 
QS-disrupter 145 increases the survival of giant freshwater 
prawn Macrobrachium rosenbergii larvae when challenged 
to pathogenic Vibrio harveyi [170]. 
 
In 2015, Chan and coworkers carried out a study in 
which they fabricated on microarc-oxidized titanium a new 
antibacterial agent, compound 145 loaded poly(L-lactic 
acid) nanoparticles, and found that this antibacterial 
coating produced a unique inhibition zone against 
Stapylococcus aureus throughout a 60-day period, which is 
long enough to prevent the infection around implants in the 
early and intermediates stages [171]. 
 
In the same year, Quan and coworkers incorporated for 
the first time compound 145 into Nafion polymer and 
investigated the antimicrobial and anti-biofilm properties 
of the resulting composite film against mixed culture and 
three strans of P. aeruginosa, E. coli and Bacillus subtilis 
[172]. The results indicated that 145 or Nafion alone could 
inhibit all colonization and that when 145 was incorporated 
into the Nafion polymer, synergetic anti-biofilm effects 
were obtained [172]. 
 
Finally, still in 2015, Li and coworkers obtained results 
showing that 145 efficiently inhibits biofilm formation by 
Acidithiobacillus ferroxidans (a Gram-negative bacterium 
commonly found in acid mine drainage and deep caves) 
and that the inhibition of biofilm formation is correlated 
with a decrease in the production of extracellular 
polymeric substance [173]. Notably, the reduction in the 
production of extracellular substances led to reduced 
biofilms on pentlandite, the most common terrestrial nickel 
sulfide, and to reduced pentantlandite attachment [173]. 
 
In 2008 Ren, Luk and coworkers synthesized (E)-4-
bromo-5-(bromomethylene)-3-methyl-2(5H)-furanone 
(249) (BF-8) by bromination of 2-methyllevulinic acid 
(248), followed by oxidative ring closure under acidic 
conditions of the resulting dibrominated compound 
(Scheme 90) [174]. 
 
 
 
Scheme 90. Synthesis of compounds 249–251  
 
Notably, the reaction also produced 4-bromo-5-
(dibromomethylene)-3-methyl-2(5H)-furanone (250) (BF-
9) and 4-bromo-5-(dibromomethyl)-3-methyl-2(5H)-
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furanone (251) (BF-14) in 12% and 2.7% yield, 
respectively (Scheme 90) [174]. Interestingly, compound 
249 was found to exhibit significant inhibition activity for 
E. coli biofilm formation [174].  
 
In 2012, Ren and coworkers showed that 249 could also 
act synergistically with antibiotics to enhance killing of P. 
aeruginosa PAO1 persister cells (a subpopulation of 
bacterial cells that are dormant and tolerant to antibiotics) 
and could also restore the susceptibility of isolated 
persister cells to antibiotics [175]. 
 
One year later, Ren and coworkers demonstrated that 
the QS inhibitor 249 (BF-8) could reduce persistance 
during the growth of E. coli and revert the antibiotic 
tolerance of its persister cells [176]. Again in 2013, the 
same research group characterized the effects of compound 
249 on the mucoid strain P. aeruginosa PDO300 and found 
that this brominated furanone is able to reduce persistence 
during the growth of P. aeruginosa PDO300 and 
effectively to kill the persister cells isolated from this strain 
[177]. Furthermore, compound 249 was capable to inhibit 
biofilm formation of PDO300 and to reduce associated 
persistence [177]. 
 
In 2009, Kumar and coworkers carried out the synthesis of 
4-substituted (Z)-3-bromo-5-(bromomethylene)-2(5H)-
furanones 257a–h by using the reaction sequence outlined 
in Scheme 91 [178]. Thus, addition of bromine to 
carboxylic acids 252, followed by cyclodehydration of the 
resulting dibromolevulinic acids 253 with P2O5 in CH2Cl2 
gave compounds 254 in moderate to good yields. 
Dehydrobromination of these substances with DBU in 
CH2Cl2 yielded 5-methylene-2(5H)-furanones 253, which 
were reacted with bromine to give selectively compounds 
256. Finally, dehydrobromination of these substances with 
i-Pr2NEt in CH2Cl2 provided compounds 257 
stereoselectively and in moderate to satisfactory yields. For 
instance, the reaction of 256d (R = n-Hex) with 3.4 equiv 
of i-Pr2NEt in CH2Cl2 at room temperature for 72 h 
produced compound 257d in 55% yield [178]. However, 
the stereoisomeric purities of compounds 257 were not 
reported [178]. 
 
 
 
 
Scheme 91. Synthesis of 4-substituted (Z)-3-bromo-5-
(bromomethylene)-2(5H)-furanones 257a–h     
 
In 2015, Barbosa and coworkers synthesized (Z)-5-(1-
arylmethylene)-3-bromo-4-(5-bromo-2-methoxyphenyl)-
2(5H)-furanones 91k–o via a route (Scheme 92) in which  
the first step was the PdCl2(MeCN)2/AsPh3-catalyzed 
regioselective C-4 arylation reaction of 3,4-dibromo-
2(5H)-furanone (2) with 5-bromo-2-methoxyphenylboronic 
acid  (258) in THF at 65 °C in the presence of  Ag2O [76]. 
The resulting 3-bromo-4-(5-bromo-2-methoxyphenyl)-
2(5H)-furanone (31g), which was obtained in 29% yield, 
was reacted with 2.2 equiv of TBDMSOTf, 3.0 equiv of i-
Pr2NEt and 1.1 equiv of the required aryl aldehydes in 
CH2Cl2 at room temperature and the crude reaction 
products were treated with 2.2 equiv of DBU under reflux 
providing compounds 91k–o in 40–63% yield based on 
31g (Scheme 92) [76]. The lowest yield was obtained by 
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using an aryl aldehyde with the strong electron-
withdrawing CF3 substituent [76]. 
 
 
 
Scheme 92. Synthesis of (Z)-5-(1-arylmethylene)-3-
bromo-4-(5-bromo-2-methoxyphenyl)-2(5H)-furanones 
91t-x 
 
In 2016, Barbosa and coworkers found that compound 
91n caused a decrease in HL-60 cell viability followed by 
an increase in the apoptoric and necrotic cells in a 
concentration dependent manner [179]. 
 
The year before, Bouillon, Médebielle and coworkers 
prepared (Z)-3-bromo-5-(4-bromobenzylidene)-4-
methoxy-2(5H)-furanone (102h) in 73% yield by treatment 
of a 89 : 11 (Z)/(E)- mixture of 5-(4-bromobenzylidene)-4-
methoxy-2(5H)-furanone (101h) with 1.5 equiv of bromine 
and 1.2 equiv of pyridine in CH2Cl2 at room temperature 
(Scheme 93) [82]. 
 
 
 
Scheme 93.  Synthesis of (Z)-3-bromo-5-(4-
bromobenzylidene)-4-methoxy-2(5H)-furanone (102h)    
 
The stereoisomeric mixture of compound 101h was in 
turn prepared in 44% yield from 4-methoxy-2(5H)-
furanone (98a) according to the reaction sequence outilined 
in Scheme 35 [82]. 
 
In concluding this section, it deserves also to be 
mentioned that, in 2001, our research group synthesized 
(Z)-3-bromo-4-(3-chloro-4-methoxyphenyl)-5-[1-(3-
bromo-4-methoxyphenyl)methylene]-2(5H)-furanone (229) 
(Figure 18) in 87% yield by using the procedure developed 
to prepare compounds 89a and 89b (Scheme 32) [74]. 
Compound 229 was then O-demethylated by treatment 
with 5.0 equiv of BBr3 in CH2Cl2 at room temperature for 
48 h providing the rubrolide analogue 226 (Figure 21)in 
51% yield [74]. 
 
 
 
Figure 21.  Structures of compounds 229 and 226    
 
Notably, compounds 229 and 226 proved to be highly 
cytotoxic for MCF-7, NCI-H460 and SF-268 cancer cell 
lines. In fact, their values for the growth reduction of any 
one of the cell lines were negative numbers, which 
indicated cell kill [74]. 
 
  
5.  SYNTHESIS AND BIOACTIVITY OF 2(5H)-
FURANONE DERIVATIVES FEATURING ONE 
BROMINE ATOM ON THE HETEROCYCLIC RING 
AND DIBROMINATED SUBSTITUENTS 
 
In 1997, 3-bromo-4-(dibromomethyl)-2(5H)-furanone 
(261) was synthesized by LaLonde and coworkers starting 
from 4-acetoxymethyl-2(5H)-furanone (259) via the route 
outlined in Scheme 94 [162]. In particular, the reaction of 
259 with 3.1 equiv of bromine in CH2Cl2 for 10 d, 
followed by treatment with 1.04 equiv of Et3N gave 
compound 260 in 40% yield. Acidic hydrolysis of the ester 
group of 260 in methanol furnished compound 261 in 77% 
yield. The subsequent reaction of 261 with a mixture of 2.1 
equiv of pyridinium chlorochromate (PCC) and 31.3 equiv 
of NaCl in CH2Cl2 gave 3-bromo-4-formyl-2(5H)-furanone  
(262) in 76% yield. Finally, treatment of this compound 
with the reagent prepared from equimolar amounts of 
bromine and triphenylphosphite led to the target compound 
263 in 53% yield (Scheme 94) [162]. It was then found that 
263 was mutagenic in the Salmonella typhimurium 
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(TA100-S9) assay with a mean mutagenicity value of 82.4 
revertants/mmol [162]. 
 
 
 
Scheme 94. Synthesis of 3-bromo-4-(dibromomethyl)-
2(5H)-furanone (263)    
 
In 2000, 3-bromo-4-(dibromomethyl)-5-hydroxy-2(5H)-
furanone (264a) (Figure 22), which is the brominated 
analogue of the potent environmental mutagen 3-chloro-4-
(dichloromethyl)-5-hydroxy-2(5H)-furanone (264b) (MX) 
(Figure 22) [180–182], was synthesized by the reaction 
sequence illustrated in Scheme 95 [183]. 
 
 
 
Figure 22. Structures of compounds 264a and 264b 
(MX)  
 
The synthesis began with the addition of bromine to 
methyl 3-methyl-2-butenoate (265a) and the subsequent 
dehydrobromination with Et3N of the resulting adduct, 
which led to compound 266 in 77% yield. 
 
 
 
Scheme 95. Synthesis of 3-bromo-4-(dibromomethyl)-
5-hydroxy-2(5H)-furanone (264a) 
 
At first, three bromine atoms were introduced by 
treatment of this compound with 4.2 equiv of NBS in CCl4 
under irradiation for 6 h and.  The subsequent introduction 
of the fourth bromine atom into the resulting product(s) 
was accomplished by treatment with 1.3 equiv of NBS in 
CCl4 under irradiation for 3 d. In this way compound 267 
was obtained in 40% yield. Finally, 267 was converted to 
3-bromo-4-(dibromomethyl)-5-hydroxy-2(5H)-furanone 
(264a) in 48% yield by treatment with 48% HBr under 
reflux for 8 h [183]. 
 
It is interesting to note that, previously, 264a had been 
found to be present in chlorinated drinking waters in 
concentrations comparable to that of 264b (MX) [184]. 
 
In 2008, Ren, Luk and coworkers reported that the 
reaction of 5-(dibromomethylene)-3-methyl-2(5H)-
furanone (250) with 2.0 equiv of NBS in CCl4 under reflux 
for 12 h, in the presence of 0.2 equiv of dibenzoyl 
peroxide, provided a mixture of 3-bromo-5-
(dibromomethylene)-2(5H)-furanone (268) (BF-11) and 3-
(dibromomethyl)-5-(dibromomethylene)-2(5H)-furanone 
(269) (BF-10) (Scheme 96) [174]. Column 
chromatography of this mixture allowed to obtain pure 
compounds 268 and 269 in 50% and 13% yield, 
respectively [174]. Compound 250 was in turn obtained in 
18% yield by bromination of 2-methyllevulinic acid (248), 
followed by oxidative ring closure under acidic conditions 
of the resulting brominated derivative [174]. Data were 
also obtained suggesting that 268 is bactericidal to 
Escherichia coli [174]. 
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Scheme 96. Synthesis of compounds 268 and 269   
 
One year earlier, Haval and Argade had described a 
synthesis of a mixture of naturally-occurring (Z)-4-bromo-
5-(dibromomethylene)-3-butyl-2(5H)-furanone (211) and 
(Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone 
(196) via a multi-step reaction sequence in which N-(4-
tolyl)maleimide (270) was used as the starting material 
(Scheme 97) [185]. Specifically, compound 270 was 
converted to 3-butylfuran-2,5-dione (271) in 61.5 % yield 
through a five-step sequence. The reaction of 271 with 1.1 
equiv of methylmagnesium iodide in Et2O at –20 °C 
followed by hydrolysis gave 3-butyl-5-hydroxy-5-methyl-
2(5H)-furanone (272) and 4-butyl-5-hydroxy-5-methyl-
2(5H)-furanone (273) in 62% and 9% yield, respectively. 
The subsequent treatment of compound 272 with P2O5 in 
benzene under reflux provided the expected butenolide 
274. Finally, addition of 2.2 equiv of bromine to 274 
followed by reaction of the resulting adduct with 2.2 equiv 
of Et3N in CHCl3 gave a mixture of fimbrolides 211 and 
196, which were separated by HPLC using a known 
procedure [140]. Compounds 211 and 196 were so 
obtained in 18% and 37% yield, respectively (Scheme 97) 
[185]  
 
 
 
Scheme 97. Synthesis of naturally occurring 
fimbrolides 211 and 196  
 
It should be noted that Givskov and coworkers had 
previously found that compound 211, similarly to 196, is 
able to inhibit swarming motility of the Gram-negative 
bacterium Serratia liquefaciens MG1 and to control 
transcription of the QS regulated gene swrA in competition 
with the cognate signal molecule BHL [148]. 
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In 1966, 4-bromomethyl-3-ethoxycarbonyl-2(5H)-
furanone  (277 ) was synthesized in two steps starting from 
diethyl isopropylidenemalonate (275) (Scheme 98) [186]. 
 
 
 
Scheme 98.  Synthesis of 4-bromomethyl-3-
ethoxycarbonyl-2(5H)-furanone  (277)   
 
The reaction of 275 with 2.1 equiv of NBS in CCl4 
under reflux and irradiation with a 200 W lamp produced 
compound 276 in 40% yield. The subsequent reaction of 
276 with trifluoroacetic acid at 80 °C for 48 h yielded the 
required compound 277 in 53% yield [186]. 
 
In 1976, Martin and coworkers carried out the synthesis 
of 4-bromomethyl-2(5H)-furanone (231) in 28.8% overall 
yield by treatment of ethyl 3-methyl-2-butenoate (265b) 
with 2.17 equiv of NBS in CCl4 under reflux and 
irradiation with a 100 W lamp and cyclization of the 
resulting compound 278 by reaction with 48% HBr under 
reflux (Scheme 99) [113]. 
 
 
 
Scheme 99. Synthesis of 4-bromomethyl-2(5H)-
furanone (231) 
 
In 1983, Kotsuki, Monden and Ochi described an 
efficient synthesis of (Z)-3-(1-acetoxybutyl)-5-
(bromomethylene)-2(5H)-furanone (285) in which methyl 
levulinate dimethyl ketal (279) was used as the starting 
material (Scheme 100) [187]. 
 
 
 
Scheme 100.  Synthesis of (Z)-3-(1-acetoxybutyl)-5-
(bromomethylene)-2(5H)-furanone (286)   
 
Formylation of 279 and treatment of the resulting crude 
product 280 with Amberlyst H-15 produced methyl 5-
methyl-3-furoate (281) in a satisfactory yield. Reduction of 
281 with LiAlH4 in Et2O followed by oxidation of the 
resulting alcohol with pyridinium dichromate (PDC) in 
CH2Cl2 gave 5-methyl-3-formylfuran (282), which was 
then converted to compound 283 in 43.3% overall yield by 
treatment with propylmagmesium iodide and acetylation of 
the resulting alcohol. Oxidation of 283 with 2.0 equiv of 
m-chloroperbenzoic acid in CH2Cl2 at room temperature in 
the presence of 2.0 equiv of NaHCO3 led to a 
diastereomeric mixture of 2(5H)-furanone 284 in 86% 
yield. This compound was dehydrated with P2O5 in 
benzene under reflux providing 5-methylene-2(5H)-
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furanone 285 in 70% yield. Finally, addition of bromine to 
285 in the presence of a catalytic amount of 
hydroquininone and the subsequent dehydrobromination of 
the resulting adduct by treatment with DBU at –10 °C led 
to compound 286 in 95% yield (Scheme 100) [187]. 
 
Four years later, Font and coworkers synthesized 3-(1-
bromobutyl)-2(5H)-furanone (292) from commercially 
available g-butyrolactone (287) through a route in which 3-
(1-hydroxybutyl)-2(5H)-furanone (291) was the 
unexpected direct precursor to 292 (Scheme 101) [188]. 
 
 
 
Scheme 101. Synthesis of 3-(1-bromobutyl)-2(5H)-
furanone (292)    
 
Specifically, lactone 287 was converted to 3-
(phenylthio)-4,5-dihydrofuran-2(3H)-one (288) and the a-
carbanion of this compound was reacted with butanal (289) 
providing compound 290 as a 1 : 1 diastereomeric mixture 
in 84% yield. Oxidation of 290 with m-CPBA in CH2Cl2 at 
0 °C for 1 h or with sodium periodate in a 1 : 1 mixture of 
water and methanol at room temperature for 17 h, followed 
by pyrolysis of the resulting sulfoxide gave compound 291 
in 65–80% yield.  Finally, the substitution of the allylic 
hydroxyl group in 291 with bromine occurred 
unexpectedly under typical bromination conditions. In fact, 
treatment of 291 with 1.0 equiv of bromine in CCl4 gave 
bromide 292 in 52% yield (Scheme 101) [188]. 
 
In 1995, Sánchez-Ferrando and coworkers reported a 
two-step synthesis of 5-(1-bromoethyl)-2(5H)-furanone 
(294) in which sorbic acid (18) was the starting material 
(Scheme 102) [36]. In particular, the reaction of 18 with 
1.25 equiv of bromine in water at 85 °C for 1 h and then 
for 2 h at room temperature gave (E)-5-bromo-4-hydroxy-
2-hexenoic acid (293) in 35% yield.  The subsequent 
reaction of 293 in acidic water under UV irradiation 
provided compound 294 in 70% yield (Scheme 102) [36]. 
 
 
 
Scheme 102. Synthesis of 5-(1-bromoethyl)-2(5H)-
furanone (294) 
 
In 2000, 4-(bromochloromethyl)-3-chloro-5-hydroxy-
2(5H)-furanone (297) (BMX-1) and 3-chloro-4-
(dibromomethyl)-5-hydroxy-2(5H)-furanone (298) (BMX-
2) were synthesized by Messeguer and coworkers from 
methyl-3-methyl-2-butenoate (265a) using the reaction 
sequence outlined in Scheme 103 [183, 189]. 
 
 
 
Scheme 103. Synthesis of compounds 297 (BMX-1) 
and 298 (BMX-2) 
 
Chlorination of 265a by treatment with 2.4 equiv of 
chlorine in CCl4 solution at room temperature, followed by 
dehydrochlorination with 0.5 equiv of Et3N in CH2Cl2 led 
in 55% yield to a stereoisomeric mixture of 295 in which 
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the E- and Z-stereoisomers were in a 1.8 : 1 ratio. This 
mixture was subjected to allylic bromination with an 
excess of NBS in the presence of light at 110 °C producing 
a mixture of (E)- and (Z)-296 in a 1 : 1 ratio and in only 
18% yield. Finally, hydrolysis and subsequent cyclization 
of this mixture by treatment with 70% methanesulfonic 
acid at 140 °C gave a mixture of compounds 297 (BMX-1) 
and 298 (BMX-2) from which pure compounds 297 and 
298 were isolated in 25% and 20% yield, respectively, via 
reversed phase HPLC [183,189]. 
 
In 2003, Lumbard and coworkers described a simple 
synthesis of 297 (BMX-1), 298 (BMX-2) and 3-bromo-4-
(dibromomethyl)-5-hydroxy-2(5H)-furanone (299) (BMX-
3) from 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-
furanone (264b) (MX) (Scheme 104) [190]. 
 
 
 
Scheme 104. Synthesis of compounds 297–299 from 
264b (MX) 
 
They reported that the reaction of MX with 110 equiv of 
ethyl bromide and 0.45 equiv of NaBr in dry 1-methyl-2-
pyrrolidinone at 75 °C for 28 h gave BMX-1 and BMX-2 
in 18% and 21% yield, respectively. They also found that 
treatment of MX with 88.1 equiv of ethyl bromide and 2.0 
equiv of NaBr in dry 1-methyl-2-pyrrolidinone at 100 °C 
for 24 h produced BMX-2 and BMX-3 in 6% and 32% 
yield, respectively (Scheme 104) [190]. 
 
In 2000, Messeguer and coworkers evaluated the 
mutagenic activity of compounds BMX-1, BMX-2 and 
BMX-3 by employing the Ames test with Salmonella 
typhimurium strain TA98 and TA100 and found that the 
mutagenic potencies in TA100 without S9 metabolic 
activation were 22.05 ± 3.15 revertants/ng for BMX-1 
(297), 28.64 ± 2.65 revertants/ng for BMX-2 (298) and 
37.29 ± 5.73 revertants/ng for BMX-3 (299) [189]. 
Notably, the mutagenic potencies proved to be six-to-nine 
fold lower in the TA98 strain without metabolic activation 
[189]. 
 
In 2002, our research group described the first synthesis 
of rubrolide M {(Z)-5-[1-(3-bromo-4-
hydroxyphenyl)methylene]-3-chloro-4-(4-hydroxyphenyl)-
2(5H)-furanone} (304) (Scheme 105) [123], a natural 
compound isolated from the ascidian Synoicum 
blochmanni [49]. 
 
 
 
Scheme 105. Regio- and stereoselective synthesis of 
rubrolide M (304) 
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The stereo- and regioselective synthesis of 304 began 
with the Suzuki-Miyaura cross-coupling reaction of 3,4-
dichloro-2(5H)-furanone (300) with 1.1 equiv of 
arylboronic acid 301 in the presence of KF as the base, a 
Pd2(dba)3/P(o-Tol)3 catalyst system and using toluene as 
solvent, which gave compound 302 in 61% yield. This 
2(5H)-furanone derivative was then treated with 1.2 equiv 
of TBDMSOTf, 3.0 equiv of i-Pr2NEt and 1.0 equiv of 3-
bromo-4-methoxybenzaldehyde (228) in CH2Cl2 at room 
temperature and the resulting crude aldol derivative was 
treated with 2.0 equiv of DBU at room temperature for 6 h. 
Acidification of the resulting reaction mixture led to 
conpound 303 in 46% yield, which on treatment with 7.0 
equiv of BBr3 in CH2Cl2 at room temperature, followed by 
hydrolysis provided rubrolide M (304) in 97% yield [123]. 
 
In 2003, we evaluated the cytotoxic activity in vitro of 
rubrolide M against the NCI three-cell line panel consisting 
of MCF-7, SF-268 and NCI-H460 cancer cells and found 
that this compound was significantly cytotoxic against all 
three cell lines [191]. 
 
In 2004, Brückner and coworkers described low 
yielding stereoselective routes to (Z)-5-[trans-1-bromo-3-
phenyl-2-propenylidene]-2(5H)-furanone (306) and (Z)-5-
(1-bromo-1-phenylmethylene)-2(5H)-furanone (308) in 
which of 3,5-dibromolevulinic acid (144) was the starting 
material (Scheme 106) [102]. 
 
 
Scheme 106. Stereoselective synthesis of compounds 
306 and 307     
The syntheses began with the reaction of easily accessible 
compound 144 [103,192] with a 2 : 1 mixture of oleum and 
concd. sulfuric acid at 50–60 °C for 6 min, which led to 5-
(dibromomethylene)-2(5H)-furanone (305) in 28% yield. 
The subsequent Pd(dba)2/AsPh3-catalyzed Stille-type 
reaction of 305 with (E)-2-phenylethenyltributyltin (146) 
in THF at 65 °C produced stereoisomerically pure 306 in 
67% yield. Furthermore, an analogous Pd(dba)2/AsPh3-
catalyzed cross-coupling reaction of 305 with 
phenyltributyltin (30b) provided compound 307 in 84% 
yield [102]. 
 
One year later, Brückner and coworkers synthesized 
(Z)-5-(bromomethylene)-2(5H)-furanone (308) in 51% 
yield by stereoselective reduction of 5-
(dibromomethylene)-2(5H)-furanone (305) with 1.1 equiv 
of Bu3SnH in THF at 65 °C in the presence of 10 mol% 
Pd(PPh3)4 (Scheme 107) [192]. Compound 308 was in turn 
obtained in 55% yield by treatment of 3,5-
dibromolevulinic acid (144) with 1.2 equiv of P4O10 in 
CH2Cl2 under reflux, followed by reaction with 1.03 equiv 
of Et3N in CH2Cl2 at first at 0 °C and then under reflux for 
1 h (Scheme 107) [192]. 
 
 
 
Scheme 107. Stereoselective synthesis of (Z)-5-
(bromomethylene)-2(5H)-furanone (307)    
 
In 2006, Benneche and coworkers developed a synthesis 
of (Z)-5-(bromomethylene)-2(5H)-furanone (308) and its 
(E)-stereoisomer, 311 (Scheme 108) [193] starting from 
the a,b-unsaturated ester 309 [194]. They reported that 
treatment of 309 with TFA in CH2Cl2 at room temperature 
for 2 h gave (E)-2-(5-oxofuran-2(5H)-ylidene)acetic acid 
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(310) in quantitative yield. They then found that addition 
of 4.0 equiv of bromine to 310 in CDCl3 solution, followed 
by treatment of the resulting adduct with 1.08 equiv of 
Et3N in a microwave oven for 1 mn in the presence of 
DMF (Method A) gave 311 in 7% yield together with 308 
in 46% yield. On the other hand, the halodecarboxylation 
reaction of 310 with 1.07 equiv of bis(2,4,6-
trimethylpyridino)bromine(I) hexafluorophosphate [Br+ 
(coll)2PF6-] [195] in CH2Cl2 at 0 °C for 15 min and at room 
temperature for 2 h (Method B) gave stereoisomerically 
pure 311 in 22% yield (Scheme 108) [193]. 
 
 
Scheme 108. Synthesis of (E)- and (Z)-5-
(bromomethylene)-2(5H)-furanone, (311) and (308), 
respectively 
 
More recently, Benneche and coworkers synthesized in 
77% yield a mixture of (E)- and (Z)-5-(bromomethylene)-
2(5H)-furanone in a 91 : 9 ratio, respectively, by reactiong 
5-methoxyfurfural (312) with 1.13 equiv of oxalyl bromide 
(110) in CH2Cl2 (Scheme 109) [196]. 
 
 
 
Scheme 109. Synthesis of a mixture of (E)- and (Z)-5-
(bromomethylene)-2(5H)-furanone from 5-
methoxyfurfural (312) 
 
(Z)-5-(Bromomethylene)-2(5H)-furanone (308) has also 
been the subject a several studies concerning its biological 
activity.  In 2002, Givskov and coworkers reported that this 
compound is capable of interfering with N-acyl homoserine 
lactone (AHL)-mediated QS in Pseudomonas aeruginosa  
and demonstrated that it specifically represses expression 
of a PlasB-gfp reporter fusion without affecting growth or 
protein synthesis and reduces the production of important 
virulence factors [197]. They also applied 308 to P. 
aeruginosa biofilms and found that the green fluorescent 
protein (Gfp) analysis that 308 penetrates microcolonies 
and blocks cell signaling and QS in most biofilm cells 
[197]. 
 
In 2004, Wu and coworkers showed that 308 interfers 
with the action of AHL molecules and inhibits gene 
expression regulated by QS systems in P. aeruginosa in 
vivo [168]. These authors also found that 308 exerts 
favourable therapeutic effects in P. aeruginosa lung 
infections in mice [168]. 
 
In 2007, Lönn-Stensrud and coworkers found that 308 
inhibits biofilm formation and bioluminescence induction 
by Streptococcus anginosus, S. intermedius and S. mutans 
as well as bioluminescence induction by Vibrio harveyi 
BB152 [198]. 
 
In 2013, Vestby and coworkers investigated the use of 
compound 308 against the establishment of biofilm by 
Salmonella serotype Agona and E. coli O103:H2 and found 
that this brominated furanone inhibits biofilm formation 
without being bactericidal [199]. They also demonstrated 
that 308 effects both swimming and swarming motility 
without, however, affecting the expression of flagella 
[199]. 
 
In the same year, Luk and coworkers carried out the 
synthesis of (Z)-5-(1-bromoethylidene)-2(5H)-furanone 
(315) in three steps and 45% overall yield starting from 4-
oxohexanoic acid (313) (Scheme 110) [200]. In particular, 
a CH2Cl2 solution of 313 was reacted with 2.0 equiv of 
bromine and a catalytic quantity of 40% HBr at room 
temperature for 1 h. The resulting crude dibromocarboxylic 
acid 314 was dissolved in CH2Cl2 and treated with 2.0 
equiv of P4O10 at 0 °C for 0.5 h and then heated at reflux 
for 1.5 h. Finally, the solid intermediate, which was 
obtained by centrifugation of the reaction mixture, was 
reacted with 1.03 equiv of Et3N at 0 °C for 1 h and under 
reflux for 1 h providing 315 (BF-15) in 45% yield based on 
313 (Scheme 110) [200]. 
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Scheme 110. Synthesis of (Z)-5-(1-bromoethylidene)-
2(5H)-furanone (315) 
 
Interestingly, compound 315 was found capable to 
inhibit the production of the virulence factor elastase B of 
P. aeruginosa PAO1 with little inhibition of biofilm 
formation [200]. 
 
In 2012, 3-alkoxycarbonyl-5-aryl-5-bromomethyl-
2(5H)-furanones 318 were synthesized by Hassanabadi and 
coworkers via a one-pot process involving the reaction of 
phenacyl bromides 316 with equimolar amounts of dialkyl 
acetylenedicarboxylates 317 and 1.0 equiv of PPh3 in 
CH2Cl2 at room temperature for 24 h [201]. This protocol 
allowed the authors to prepare compounds 318a, 318b and 
318c in 88%, 6% and 92% yield, respectively (Scheme 
111) [201]. 
 
 
 
Scheme 111. One-pot synthesis of compounds 318a–c    
 
In 2013, Soulère, Queneau and coworkers carried out 
the synthesis of (Z)-3-alkyl-5-(bromomethylene)-2(5H)-
furanones 324a and 324b, which are analogues of 
naturally-occurring bacterial QS inhibitors, via a novel 
reaction sequence in which a-phenylthio-g-buryrolactone 
(319) was used as the starting material (Scheme 112) 
[202]. Specifically, treatment of 319 with LDA in THF at –
78°C followed by addition of the required alkyl iodides in 
HMPA at –78 °C gave 3-alkyl-3-phenylthiodihydrofuran-
2(3H)-ones 320a and 320b in good yields. Subsequent 
oxidation-elimination reaction of these substances by 
treatment with MCPBA in CH2Cl2 at 0 °C provided 
compounds 321a and 321b in 81% and 86% yield, 
respectively. They were converted to the corresponding 5-
methylene-2(5H)-furanones 323a and 323b in 34% and 
58% yield, respectively, by treatment with LDA in THF at 
–78 °C and then with dimethylmethylideneammonium 
iodide (322) (Eschenmoser’s salt). Finally, a bromine 
addition-elimination sequence [185] allowed to obtain 
compounds 324a and 324b in 56% and 37% yield, 
respectively (Scheme 112) [202]. 
 
 
 
Scheme 112. Stereoselective synthesis of compounds 
324a and 324b 
 
Soulère, Queneau and coworkers also synthesized (Z)-5-
(bromomethylene)-3-[1-(hydroxyalkyl)]-2(5H)-furanones 
328a–c through a route in which 319 was the starting 
material (Scheme 113).  
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Scheme 113. Synthesis of (Z)-5-(bromomethylene)-3-
[1-(hydroxyalkyl)]-2(5H)-furanones 329a–c  
 
The reaction of 319 with 1.5 equiv of LDA in THF at –
78 °C for 0.5 h followed by addition of 1.0 equiv of the 
required alkyl aldehydes in HMPA at –78 °C produced 
compounds 325a–c in yields ranging from 55% to 80%. 
An oxidative elimination reaction, which was carried out 
by treatment of 325a-c with 1.5 equiv of MCPBA in 
CH2Cl2 at 0 °C gave 3-(1-hydroxyalkyl)-2(5H)-furanones 
326a–c in high yields. These compounds were then 
efficiently converted to the corresponding 5-methylene 
derivatives, 327a–c, in satisfactory yields by using 
Eschenmoser’s salt 322. Finally, a bromine addition-
elimination sequence, which was carried out by a 
procedure identical to that used to prepare compounds 
324a,b, provided 328a in 48% yield and 88% 
stereoisomeric purity, and stereoisomerically pure 
compounds 328b and 328c in 31% and 49% yield, 
respectively (Scheme 113) [202]. 
 
Soulère, Queneau and coworkers also tested compounds 
324a, 324b, 325a–b, 328a-c, and 329a-c for their ability to 
inhibit the Vibrio fischeri QS system and found thay (Z)-3-
butyl-5-(bromomethylene)-2(5H)-furanone (325a) with an 
IC50 of 0.6 µM was the most active compound among all 
these fimbrolide analogues. It was also verified that, for 
this substance, the bioluminescence inhibition did not 
result from antimicrobial activity rather than QS inhibition 
[202]. 
 
In 2014, in a study on the effect of bicyclic brominated 
furanones (BBF) on QS, Wang, Luk and coworkers 
synthesized compounds 329 (5-BBF), 330 (6-BBF) and 
331 (7-BBF) (Figure 23) [25]. 
 
 
 
Figure 23. Structures of bicyclic brominated furanones 
329–331 
 
The synthesis of compound 329 was carried out in only 
3% yield by treatment of 2-oxocyclopentaneacetic acid 
(332) with 1.95 equiv of bromine at 0 °C for 40 min and 
then at room temperature for 100 min, followed by 
cyclization of the resulting dibrominated carboxylic acid 
333 with P2O5 in CH2Cl2 at 0 °C for 0.5 h and then under 
reflux for 2 h. Finally, dehydrobromination of the resulting 
crude compound 334 by treatment with 1.04 equiv of Et3N 
at first at 0 °C and then under reflux for 2 h gave 
compound 329 (5-BBF) (Scheme 114) [25].  
 
 
 
Scheme 114. Synthesis of compound 329 (5-BBF)    
 
A similar reaction sequence involving 2-
oxocyclohexaneacetic acid (336), which was obtained by 
saponification of the corresponding ethyl ester 335 allowed 
for the preparation of compound 330 (6-BBF) in 16% 
overall yield (Scheme 115) [25]. 
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Scheme 115. Synthesis of compound 330 (6-BBF)     
 
The synthesis of 331 (7-BBF) was instead carried out 
starting from cycloheptanone (337) (Scheme 116).  
Specifically, 337 was reacted with 3.56 equiv of NaH in 
benzene and the resulting enolate was treated with 2.5 
equiv of dimethyl carbonate (338) providing crude methyl 
2-oxo-1-cycloheptanecarboxylate (339). An acetone 
solution of 339 was then treated with 4.7 equiv of K2CO3 
and 0.94 equiv of ethyl bromoacetate (340) and the 
resulting mixture was refluxed for 17 h. The oil, which was 
obtained after concentration of the reaction mixture, was 
treated with a mixture of 6 M HCl and acetic acid 
providing compound 341 in 87% yield based on 337. 
Finally, dibromination of this intermediate, dehydration 
and Et3N-mediated elimination produced compound 331 
(7-BBF) in 10% yield (Scheme 116) [25]. 
 
Next, 5-BBF, 6-BBF and 7-BBF were found to interfere 
with QS and QS-controlled activitites in Gram-negative 
bacteria. In fact, these compounds appeared able to inhibit 
biofilm formation by E. coli and P. aeruginosa and to 
inhibit elastase B production by P. aeruginosa at 
nonmicrobicidal concentrations [25]. The effect of 
compounds 5-BBF, 6-BBF and 7-BBF on biofilm 
formation of P. aeruginosa was investigated using a wild 
strain PA01-GFP, which constitutively expresses green 
fluorescence proteins [203] and enables easy and direct 
visualization of biofilm. In the initial screening, it was 
found that, at 400 µM, 6-BBF provided more inhibition 
than 5-BBF and 7-BBF. Results were also obtained 
showing that 6-BBF and 7-BBF exhibit antagonistic 
activities for the transcriptional activator LasR protein in 
the lasl QS circuit in P. aeruginosa, while 5-BBF is a 
strong agonist of the rhil QS circuit [25]. 
 
 
 
Scheme 116. Synthesis of compound 331 (7-BBF) 
 
In the last two decades, significant interest has also been 
directed to the synthesis and evaluation of the biological 
properties of 2(5H)-furanones featuring monobrominated 
aryl substituents. In 2000, Pour and coworkers synthesized 
racemic 3-(3-bromophenyl)-5-methyl- and 3-(4-
bromophenyl)-5-methyl-2(5H)-furanone, (344a) and 
(344b), respectively, by conversion of saturated lactones 
342a and 342b with LDA, reaction of the resulting 
enolates with phenylselenyl chloride (343), and oxidation 
with MCPBA with spontaneous selenoxide elimination of 
the resulting a-selenyl derivatives (Scheme 117) [204]. 
 
 Compounds 344a and 344b were then evaluated for 
their in vitro antifungal activity against a set of clinical 
isolates of human pathogenic fungi and it was found that 
their minimal inhibitory concentration (MIC) against 
Candida albicans after 24 h was 7.81 µmol/L for 344a and 
31.25 µmol/L for 344b. In addition, the MIC values for 
344a and 344b against Trichophyton mentagrophytes after 
72 h were proven to be 31.25 and 6.25 µmol/L, 
respectively, and to double after 120 h [204]. 
 
 
 
Scheme 117.  Synthesis of 3-(bromophenyl)-5-methyl-
2(5H)-furanones 344a,b 
 
In 2001, Pour and coworkers prepared racemic 3-(4-
bromophenyl)-5-(hydroxymethyl)-2(5H)-furanone (347) 
O
EtOOC
335
1) LiOH (3.2 equiv.)
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(Figure 24) from the corresponding saturated lactone 346 
(Figure 24) using a reaction sequence similar to that 
depicted in Scheme 117 [205]. Compound 346 was in turn 
synthesized from (4-bromophenyl)acetic acid (345) (Figure 
24) via a five-step route [205]. 
 
 
 
Figure 24.  Structures of compounds 345–348    
 
Compound 347 was subsequently converted to the 
corresponding acetate 348 (Figure 21) by acylation with 
acetyl chloride in CH2Cl2 at 0 °C in the presence of 
pyridine [205]. 
Compounds 347 and 348 were then evaluated for their 
antifungal activity against a set of human pathogenic fungi 
including the representatives of both yeast and filamentous 
strains and found that 347 exhibited a moderate antifungal 
effect which was much lower than that of the 
corresponding acetate 348, a relatively lipophilic 
compound [205]. 
 
In 2004, compound 348, also indicated as LNO18–22, 
was found to exhibit a broad spectrum of activity against a 
variety of pathogenic yeasts and molds including Candida 
albicans, C. incospicua, C. krusei, Blastoschizomyces 
capitatus, the Trichosporon beigelii complex, and   
Aspergillus species with decreased susceptibility to 
fluconazole [206].  
 
In 2006, the mechanism of action of 348 against 
Candida albicans was investigated by Vale-Silva and 
coworkers by using flow cytometry [207]. They 
determined that the potent fungicidal activity of this 
compound resulted in disruption of the plasmatic cell 
membrane of C. albicans.  
 
Four years later, Pour and coworkers converted 
compound 347 to 5-methylene-3-(4-bromophenyl)-2(5H)-
furanone (349) in 64% yield by treatment with 1.2 equiv of 
PPh3, 1.2 equiv of iodine and 1.2 equiv of imidazole in dry 
CH2Cl2 at –10 °C and then at room temperature (Scheme 
118) [208]. They then observed that 349 exhibited 
excellent activity against C. albicans ATCC44859 and C. 
glabrata strain and that this activity was identical to that of 
its precursor 347. Compound 349 was also found to 
possess moderate cytostatic activity against CCRF-CEM 
cell lines. Moreover, cell cycle analysis of CCRF-CEM 
cells following treatment with 349 showed that this 
furanone is a necrotic agent [208]. 
 
 
 
Scheme 118. Synthesis of 5-methylene-3-(4-
bromophenyl)-2(5H)-furanone (349)    
 
In 2015, 3-(bromophenyl)-5,5-dimethyl-2(5H)-
furanones 352a–c were efficiently synthesized by Mao and 
Zhu by using a practical and atom-economical method that 
involved the BF3×Et2O catalyzed, p-TsOH×2H2O-mediated 
annulation of 2-methylpropan-2-ol (350) with the required 
bromophenylglyoxylic acids 351 (Scheme 119) [209]. 
Specifically, the reaction of compounds 351a–c with 1.5 
equiv of 350 in o-xylene at 110 °C in the presence of 20 
mol% BF3×Et2O and 2.5 equiv of p-TsOH×2H2O produced 
compounds 352a, 352b and 352c in 42%, 77% and 82% 
yield, respectively [209]. 
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Scheme 119. Synthesis of 3-(bromophenyl)-5,5-
dimethyl-2(5H)-furanones 352a–c 
 
In 2012, 2(5H)-furanone 355 was synthesized by Manna 
and Mukherjee in 93% yield with high diastereo- and 
enantioselectivity by asymmetric direct vinylogous 
Michael reaction between a-angelica lactone (353) and N-
4-bromophenylmaleimide (354) in CH2Cl2 at –35 °C in the 
presence of 5 mol% the thiourea homochiral catalyst TTC 
(Scheme 120) [210]. 
 
 
 
Scheme 120. Asymmetric synthesis of 2(5H)-furanone 
355 
 
In 2015, Nakamura and coworkers reported that 
treatment of N-diphenylphosphinoylketimine 357 with 2.0 
equiv of 2(5H)-furanone (12), 10 mol% Zn(OTf)2, 10 
mol% cinchona alkaloid amide (CAA) and 1.0 equiv of 
Et3N in THF at 0 °C for 24 h in the presence of 4 Å 
molecular sieves produced in 92% yield a 1 : 99 mixture of 
syn- and anti-furanone 358 in which the e.r. for the anti-
isomer was 93 : 7 (Scheme 121) [211]. Compound 357, 
which was used in this asymmetric direct vinylogous 
Mannich reaction, was prepared from the corresponding 
methyl aryl ketone by using a literature procedure [212]. 
 
 
 
Scheme 121. Enantioselective synthesis of anti-2(5H)-
furanone 358      
 
Still in 2015, Franck and coworkers synthesized some 
analogues of cadiolide A (359a), cadiolide B (359b) and 
cadiolide C (359c) (Figure 25) [213], three brominated, 
densely functionalized 2(5H)-furanone derivatives which 
were isolated in 1998 from an Indonesian ascidian of the 
genus Botryllus [214] and in 2012 from the Korean 
tunicate Pseudodistoma antiboja [215]. 
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Figure 25. Structures of cadiolide A (359a), cadiolide B 
(359b) and cadiolide C (359c)    
 
These analogues, which included 2(5H)-furanones 
featuring monobrominated phenyl substituents, were 
evaluated against four Gram-positive bacterial strains, 
Bacillus cereus, B. subtilis, Staphylococcus aureus and 
Enterococcus faecalis, and four Gram-negative bacterial 
strains, Salmonella typhi, E. coli 100, E. coli 405 and 
Erwinia carotovora. Among the analogues with 
monobrominated substituents, (Z)-3-(3-bromo-4-
hydroxybenzoyl)-5-(3-bromo-4-hydroxybenzylidene)-4-(3-
bromo-4-hydroxyphenyl)-2(5H)-furanone (362) was the 
most potent compound with a MIC value of 1.95 µg/mL 
against B. cereus, S. aureus, E. faecalis, S. typhi and E. coli 
405 [213].  
This compound was synthesized in 44% yield by a one-
pot process involving the reaction of a-hydroxyketone 360 
with 2.0 equiv of dioxinone 361, 1.0 equiv of aldehyde 228 
and 2.0 equiv of Et3N in toluene at 150 °C under 
microwave irradiation for 15 min and the subsequent O-
demethylation of the resulting crude product by treatment 
with 10 equiv of BBr3 in CH2Cl2 at room temperature for 
20 h (Scheme 122) [213].
 
 
 
Scheme 122. One-pot synthesis of (Z)-3-(3-bromo-4-hydroxybenzoyl)-5-(3-bromo-4-hydroxybenzylidene)-4-(3-bromo-4-
hydroxyphenyl)-2(5H)-furanone (362)    
 
Interestingly, a similar one-pot procedure was used to 
prepare cadiolide analogues 363, 364 and 365 (Figure 26) 
in 38%, 37% and 30% yield, respectively [213]. 
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Figure 26. Structures of cadiolide analogues 363–365 
 
 
 
7.  SYNTHESIS AND BIOACTIVITY OF 2(5H)-
FURANONE DERIVATIVES FEATURING 
DIBROMINATED SUBSTITUENTS 
 
As mentioned in Section 6, in 2004, Brückner and 
coworkers synthesized 5-(dibromomethylene)-2(5H)-
furanone (305) by treatment of 3,5-dibromolevulinic acid 
(144) with a 2 : 1 mixture of oleum and concd. sulfuric 
acid at 50–60 °C (Scheme 106) [102]. 
  
In 2008, Ren, Luk and coworkers reported that the 
reaction of a-methyllevulinic acid (248) with 2 equiv of 
bromine at 35–40 °C for 1 h, followed by treatment of the 
resulting crude reaction mixture with 95–98% sulfuric acid 
at 110 °C for 20 min gave a mixture of 5-
(dibromomethylene)-3-methyl-2(5H)-furanone (250) (BF-
9), 4-bromo-5-(dibromomethyl)-3-methyl-2(5H)-furanone 
(251) (BF-14) and (E)-4-bromo-5-(bromomethylene)-3-
methyl-2(5H)-furanone (249) (BF-8) in 12%, 2.7% and 
13% yield, respectively (Scheme 90) [174]. These authors 
also found that the reaction of compound 250 with 2.0 
equiv of NBS in CCl4 under reflux for 12 h in the presence 
of a catalytic quantity of dibenzoyl peroxide gave 3-
(dibromomethyl)-5-(dibromomethylene)-2(5H)-furanone 
(269) (BF-10) and 3-(bromomethyl)-5-dibromomethylene-
2(5H)-furanone (268) (BF-11) in 13% and 50% yield, 
respectively (Scheme 96) [174]. Interestingly, compounds 
250 (BF-9) and 269 (BF-10) exhibited strong biofilm 
inhibition by E. coli at 60 µg/mL without effects on E. coli 
growth [174]. 
 
In 1997, Kotora and Negishi carried out the first total 
synthesis of rubrolide C (374) [216], a metabolite of the 
colonial tunicate Ritterella rubra which is a member of a 
family of compounds that are potent in vitro antibiotics and 
show moderate but selective inhibition of protein 
phosphatases I and 2A [48]. Scheme 123 outlines the 
reaction sequence used for the synthesis of this natural 
product. 
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Scheme 123. First total synthesis of rubrolide C (374)   
 
Thus, protection of the phenol group of 4-iodophenol 
(366) as TBDMS ether, followed by Pd-catalyzed reaction 
with ethynylzinc chloride (367) gave 1-alkyne 368 in 75% 
yield. This compound was then converted to 3-
(hydroxyphenyl)propynoic acid (369), which was reacted 
with Ac2O and Et3N iin CH2Cl2 and subsequently with 3 M 
HCl providing 3-(4-acetoxyphenyl)propynoic acid (370) in 
95% yield. Hydroiodination of 370 by treatment with NaI 
and AcOH at 115 °C gave stereoselectively and in a good 
yield (Z)-3-(4-acetoxyphenyl)-3-iodoprop-2-enoic acid 
(371) which underwent PdCl2(PPh3)2/CuI-catalyzed cross-
coupling/lactonization reaction by treatment witth 1-alkyne 
372 in acetonitrile in the presence of Et3N. The reaction led 
to rubrolice C diacetate (373) in 54% yield. Finally, 
treatment of 373 with 1 M K2CO3 in a mixture of MeOH 
and THF gave rubrolide C (374) in 78% yield [216]. 
 
In 1998, Boukouvalas and coworkers described another 
synthesis of rubrolide C (Scheme 124) [47] that involved a 
lower number of steps compared to that reported by Kotora 
and Negishi [216] and was higher yielding. The Pd-
catalyzed Suzuki-Miyaura cross-coupling of 4-bromo-
2(5H)-furanone (108) with arylboronic acid 301, which 
gave compound 375 in 79% yield, was first step of this 
new synthesis. 
 
 
Scheme 124. Synthesis of rubrolide C (374) from 4-
bromo-2(5H)-furanone (110) 
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Aldolization of 375 with aldehyde 376 in the presence 
of TBDMSOTf and i-Pr2NEt, followed by treatment with 
DBU gave stereoisomerically pure compound 377 in 95% 
yield. Finally, exposure of 377 to 3 equiv of BBr3 in 
CH2Cl2 led to rubrolide C (374) in 95% yled [47]. 
 
More recently, Karade and coworkers reported a new 
efficient synthesis of rubrolide C (Scheme 125) in which 
the preparation of compound 374 via intramolecular Wittig 
reaction of 2-(4-methoxyphenyl)-2-oxoethyl 2-
bromoacetate (380) with PPh3 in the presence of Et3N was 
a key step [217]. Conpound 380 was in turn obtained in 
69% yield by treatment of 4-methoxyacetophenone (378) 
with 1.2 equiv of hydroxyl(tosyloxy)iodobenzene (known 
as Koser reagent) in acetonitrile under reflux, followed by 
entrapment of the resulting compound with bromoacetic 
acid (379) in the presence of K2CO3. The synthesis of 
rubrolide C was then completed in high yield by 
Knoevenagel condensation of 375 with aldehyde 376 and 
O-demethylation of the resulting compound 382 (Scheme 
125) [217].
 
 
 
 
Scheme 125. Synthesis of rubrolide C (374) from 4-methoxyacetophenone (378) 
 
In 2010, Boukouvalas and coworkers carried out the 
first synthesis of rubrolide L {3-chloro-5-[(3,5-dibromo-4-
hydroxyphenyl)methylene]-4-hydroxyphenyl-2(5H)-
furanone} (387) [218], an antitumor metabolite of the 
ascidian Synoicum blochmanni [49], which was found to 
inhibit human aldose reductase at submicromolar level 
[219]. The synthesis of 387 was achieved via two distinct 
pathways. In the first of these (Scheme 126), commercially 
available 3-chlorotetronic acid (382) was converted to 
triflate 383 in 73% yield. The chemoselective Suzuki-
Miyaura cross-coupling reaction of 383 with 1.2 equiv of 
arylboronic acid 301 in a mixture of toluene an water in the 
presence of a Pd(OAc)2/PCy3 catalyst system, 5 mol% 
BnEt3NCl and Na2CO3 as the base gave 3-chloro-4-
methoxyphenyl-2(5H)-furanone (384) in 87% yield. The 
subsequent aldolization reaction of 384 with aldehyde 385 
in the presence of TBDMSOTf and i-Pr2NEt, followed by 
treatment with DBU provided stereoisomerically pure 386 
in 61% yield, which was then converted to rubrolide L 
(387) in 95% yield by BBr3-mediated O-demethylation 
(Scheme 126) [218]. 
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Scheme 126. Synthesis of rubrolide L (387) using 
compound 386 as an advanced intermediate     
 
The second protocol used for the synthesis of 387  
(Scheme 127) involved the conversion of compound 384 to 
(Z)-4-aryl-5-benzylidene-3-chloro-2(5H)-furanone 388. 
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Scheme 127. Synthesis of rubrolide L (387) using compound 388 as an advanced intermediate  
 
Bromination reaction of this compound using 2.0 equiv 
of bromine and 20 mol% KBr in a mixture of dioxane and 
water led to compound 389 in 96% yield. The synthesis of 
387 was then completed in 95% yield by reacting 389 with 
3 equiv of BBr3 in CH2Cl2 [218]. 
 
On the other hand, a Pd(PPh3)4/CuI-catalyzed cross-
coupling/lactonization reaction of (Z)-3-(4-acetoxy-3,5-
dibromophenyl)-3-iodoprop-2-enoic acid (390) with 1-
alkyne 372 was used in 1997 by Negishi and coworkers for 
the synthesis in 70% yield of rubrolide A diacetate (391) 
(Scheme 128) [216], the diacetyl derivative of a metabolite 
of the colonial tunicate Ritterella rubra [48] and the 
Australian ascidian Synoicum prunum [220]. 
 
 
 
Scheme 128. Synthesis of rubrolide A diacetate (390)  
 
Even naturally-occurring cadiolides A (359a), B (359b), 
C (359c) (Figure 22)  and cadiolide D (359d) (Figure 23) 
have been the subject of several synthetic studies. 
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Figure 27. Structure of cadiolide D  
 
The first total synthesis of cadiolide B i.e. (Z)-3-(3,5-
dibromo-4-hydroxybenzoyl)-4-(3,5-dibromo-4-
hydroxyphenyl)-5-[(3,5-dibromo-4-
hydroxyphenyl)methylene]-2(5H)-furanone  (359b) was 
carried out in 2005 by Boukouvalas and Poulet through the 
route outlined in Scheme 129 [221]. In particular, 4-
bromo-2(5H)-furanone (110)  was converted to compound 
393 by using an improved literature protocol [222] that 
involved the formation of a dibutylboron 2-furanolate by 
treatment of 110 with n-Bu2BOTf  in the presence of 2,6-
lutidine and the subsequent in situ aldolization reaction 
with 4-methoxybenzaldehyde (91b). The 
PdCl2(PhCN)2/AsPh3-catalyzed Suzuki-type cross-coupling 
reaction of 393 with boronic acid 302 in THF in the 
presence of Ag2O as the base gave alcohol 394, which was 
subsequently oxidized with Dess-Martin periodinane 
providing ketone 395 in high yield. Aldol reaction of 395 
with aldehyde 91b in the presence of TBDMSOTf and i-
Pr2NEt, followed by in situ b-elimination with DBU gave 
stereoisomerically pure compound 396 in 94% yield. Next, 
compound 395 was fully O-demethylated by treatment 
with BBr3 in CH2Cl2 and the resulting compound 397 was 
brominated with bromine/KBr providing cadiolide B 
(359b) in an excellent yield (Scheme 129) [221]. 
 
 
 
 
Scheme 129. First total synthesis of cadiolide B (359b)    
 
In 2013, Leleu, Franck and coworkers described another 
synthesis of cadiolide B in which (Z)-3-(4-
methoxybenzoyl)-5-(4-methoxybenzylidene)-4-(4-
methoxyphenyl)-2(5H)-furanone (399), which was used as 
an advanced intermediate, was obtained in 77% yield by 
reacting 1.0 equiv of a-hydroxyketone 397 with 1.0 equiv 
of aldehyde 88b and 2.0 equiv of [6-(4-methoxyphenyl)-
2,3-dimethyl-4H-1,3-dioxin-4-one] (398) in toluene at 150 
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°C under microwave irradiation in the presence of 2.0 equiv of Et3N (Scheme 130) [223].
 
 
 
 
Scheme 130. Synthesis of cadiolide B (359b) via the microwave-promoted . 
 
Compound 399 was converted into cadiolide B (359b) 
in 63% overall yield via a two-step route which was 
identical to that previously used by Boukouvalas and 
Poulet [221]. 
 
It deserves to be mentioned that, in 2014, that cadiolide 
B was found to exhibit antiviral activity against the 
Japanese encephalite virus at a concentration of 1 µg/mL 
[224]. 
More recently, Boukouvalas and Thibault reported the 
first synthesis of cadiolides A (359a) and D (359d) and a 
new synthesis of cadiolide B (359b) [225]. As outlined in 
Scheme 131, these compounds were synthesized by using 
the “click–unclick” Dield-Alder cycloaddition--
cycloreversion of commercially available 5-ethoxy-4-
methyloxazole (403) with ynone 404. The latter compound 
was prepared in 96% yield by PdCl2(PPh3)2/CuI-catalyzed 
cross-coupling of commercially available 4-
methoxybenzoyl chloride (400) with 4-
methoxyphenylacetylene (401) in THF at room 
temperature in the presence of Et3N as previously 
described [226–228]
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Scheme 131. Stereoselective synthesis of cadiolides A (359a), B (359b) and D (359d) 
 
MeO
Cl
O
+
OMe
O
OMe
MeO
H
PdCl2(PPh3)2 (1.97 mol%)
CuI (3.54 mol%)
Et3N (1.0 equiv.), THF, rt, 3 h
(97%)
400 (1.0 equiv.) 401 (1.0 equiv.)
402
O
N
Me
OEt
(403) (5.5 equiv.)
PhEt, 150 °C, 15 h
N
O
O
OEt
Me
OMe
MeO
- MeCN
O
OMe
MeO
O
OEt aq. HBr
THF, rt
(70%)
404
O
OMe
MeO
O
O
405
1) BBr3 (4.0 equiv.), CH2Cl3
    -78 °C, 15 min.
    rt, 24 h
2) Br2/KBr (4.0 equiv.)
    H2O/dioxane
    rt, 2 h
(84%)
O
OH
HO
O
O
406
Br Br
Br
Br
O
HO
HO
O
O
359d (cadiolide D)
Br
Br
Br
Br
H
OH
Br
O
HO
O
O
Br Br
Br
Br
H OH
Br
Br
359b (cadiolide B)
O
OH
HO
O
O
359a (cadiolide A)
Br Br
Br
Br
H OH
Br
HO
CHO
(187a) (1.5 equiv.)
(376) (1.5equiv.)
Br
HO
Br
CHO
OH
(407) (1.5equiv.)
Br
HO
CHO
piperidine (3.6 equiv.)
MeOH, rt, 28 h
(73%)
piperidine (4.0 equiv.)
MeOH, rt, 28 h
(65%)
piperidine (1.5 equiv.)
MeOH, rt, 28 h
(80%)
Send Orders for Reprints to reprints@benthamscience.net 
 Journal Name, Year, Volume 59 
 XXX-XXX/14 $58.00+.00 © 2014 Bentham Science Publishers 
 
Crude compound 404, which was obtained from the 
reaction of 402 with 403, was treated with aqueous HBr in 
THF at room temperature providing 3-(4-
methoxybenzoyl)-4-(4-methoxyphenyl)-2(5H)-furanone 
(405) in 70% yield. This compound was then treated with 
4.0 equiv of BBr3 in CH2Cl2 at –78 °C for 15 min and at 
room temperature for 24 h and the resulting crude product 
was reacted with a solution of 4 equiv of KBr3, which was 
prepared in situ from bromine and KBr [221,229] in water 
and dioxane at room temperature. In this way 3-(3,5-
dibromo-4-hydroxybenzoyl)-4-(3,5-dibromo-4-
hydroxyphenyl)-2(5H)-furanone (406) was obtained in 
84% yield. This compound was used as an advanced 
precursor to cadiolides A, B and D. Thus, by using 
classical Knoevenagel conditions (piperidine as base, 
methanol as solvent, room temperature) compound 406 
was reacted with 4-hydroxybenzaldehyde (187a), 3,5-
dibromo-4-hydroxybenzaldehyde (376) and 3-bromo-4-
methoxybenzaldehyde (407) leading to stereoisomerically 
pure compounds 359a, 359b and 359d, respectively, in 
80%, 65% and 73% yield, respectively (Scheme 131) 
[225]. 
 
Furthermore, in 2015, cadiolides C (359c) and A (359a) 
were synthesized by Franck and coworkers [213] by using 
the one-pot reaction of a-hydroxyketones, dioxinones and 
aryl aldehydes, which they had previously employed in the 
synthesis of cadiolide B (359b) [223]. As shown in 
Scheme 132, cadiolide C (359c) was obtained in 47% yield 
by reacting 1.0 equiv of a-hydroxyketone 359, 2.0 equiv of 
dioxinone 408 and 1.0 equiv of aldehyde 228 with 2.0 
equiv of Et3N in toluene under microwave irradiation at 
150 °C for 5 min and treatment of the resulting reaction 
mixture with 1 M HCl followed by BBr3-mediated O-
demethylation of the resulting product [230].
 
 
 
 
Scheme 132. One-pot multicomponent synthesis of cadiolide C (359c)  
 
 
A similar protocol allowed Franck and coworkers to 
obtain cadiolide A (359a) in 18% yield starting from a-
hydroxyketone 410, dioxinone 409 and aldehyde 88b 
(Scheme 133) [213]. 
 
Notably, cadiolide C appeared capable to inhibit the 
bacterial growth of Bacillus cereus (CECT 148), 
Salmonella typhi (CECT 409) and E. coli 405 with a  MIC 
value of 3.90 µg/mL and cadiolide A required the same 
concentration of tetracycline to inhibit the bacterial growth 
of S. typhi  and E. coli 405 with a MIC value of 8.81 
µg/mL [213].
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Scheme 133. One-pot multicomponent synthesis of cadiolide A (359a)  
 
    
Finally, in concluding this section, it is worth mentioning 
that, in 2013, Kutty, Kumar and coworkers designed, 
synthesized and evaluated some fimbrolide–nitric oxide 
donor hybrids as antimictrobial agents and found that 3-(1-
nitroxybutyl)-5-(dibromomethylene)-2(5H)-furanone 
(411a), 3-(1-nitroxydodecyl)-5-(dibromomethylene)-
2(5H)-furanone (411b) and 1-[5-(dibromomethylene)-2-
oxo-2,5-dihydrofuran-3-yl]butyl 2-(nitrooxy)acetate (412) 
(Figure 28) were particularly effective as antimicrobial 
compared to the nonhybrid naturally-occurring fimbrolides 
as revealed by Pseudomonas aeruginosa QS reporte assays 
and biofilm inbition assays [230]. 
 
 
 
Figure 28. Structures of compounds 412a,b and 413   
 
Compounds of general formula 411, including 411a and 
411b, were synthesized in high yields from the 
corresponding fimbrolide analogues 413 (Scheme 134) 
[230], which in turn were prepared by sulfuric acid-
mediated cyclization of brominated 2-alkyllevulinic acids 
[103].  Allylic bromination of compounds 413 using NBS 
as the brominating reagent in the presence of 
benzoyl5peroxide gave compounds 413 in good to 
excellent yields, which were then converted to the 
corresponding nitrooxy-substituted fimbrolides 411 in 71–
80% yield by treatment with 1.2–1.7 equiv of AgNO3 in 
acetonitrile at 70 °C. On the other hand, the fimbrolide-
nitrooxy derivative 412 was synthesized in 62.6 % overall 
yield via the two-step reaction sequence shown in Scheme 
135 [231]. 
 
 
 
Scheme 134. Synthesis of fimbrolide-nitric oxide donor 
hybrids 411  
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Scheme 135.  Synthesis of compound 412   
 
Specifically, 1.0 equiv of 3-(1-hydroxybutyl)-5-
(dibromomethylene)-2(5H)-furanone (416) was reacted 
with 1.5 equiv of bromoacetyl chloride (415) in CH2Cl2 
providing compound 417 in 87% yield. The subsequent 
reaction of 417 with 1.5 equiv of AgNO3 in acetonitrile 
under reflux gave compound 412 in 72% yield. Compound 
416 was in turn obtained in 59% yield by treatment of 
bromofimbrolide 413a with water in DMS at room 
temperature for 72 h (Scheme 136) [230]. 
 
 
Scheme 136.  Synthesis of compound 416   
 
Notably, compounds 411 and 412 were proved capable 
to release in aqueous media nitric oxide [230], a compound 
which has been shown to influence biofilm dispersal in P. 
aeruginosa [231] and to control biofilm properties at 
picomolar to nanomolar concentrations [232]. It was also 
observed that the most potent and nonbactericidal 
compound in the biofilm inhibition assay was fimbrolide-
NO donor hybrid compound 411b, which showed a 73% 
decrease in biofilm biomass [230] 
 
8. CONCLUSION 
In this article, we have attempted to give a 
comprehensive overview of the several methodologies and 
strategies that have been developed and used in the 
literature since 1951 up to the end of February 2016 for the 
synthesis of natural and unnatural 2(5H)-furanone 
derivatives bearing bromine atoms on the heterocyclic ring 
and/or brominated substituents. Attention has also been 
placed to describe, albeit in summary form, the biological 
properties of the synthesized compounds, including their 
mutagenic, enzymatic, anti-inflammatory photosynthetic 
inhibitory activity, turning however more attention to those 
derivatives that demonstrated to exhibit antimicrobial 
activity via inhibition of quorum sensing and biofilm 
fomation.  
 
In fact, as outlined in the previous sections of this 
review, in recent years numerous studies have been made 
on the identification and synthesis of brominated 2(5H)-
furanone derivatives which, acting as QS inhibitors (also 
referred as quorum quenching (QQ) compounds, are able 
to fight bacterial pathogens, including those that have 
developed resistance to antibiotics by reducing their 
virulence and biofilm formation without affecting their 
growth. These studies have been largely justified by the 
fact that the approach involving the use of QQ compounds 
has been long considered less prone to cause resistance in 
bacterial populations than that based on the use of 
antibiotics [233–235], thereby producing significant 
benefits in areas such as human health, agricolture and 
industry.  
 
Unfortunately, in recent years, these expectations have 
been at least partially questioned by the fact that results 
have been obtained showing that some bacterial strains 
such as Pseudomonas aeruginosa PAO1 and PA14 can 
manifest resistance to QS inhibitors and, among these, (Z)-
4-bromo-5-(bromomethylene)-2(5H)-furanone (C-30) 
(145) [236–238]. 
 
These data, however, do not prevent to suppose that it is 
possible to identify novel antimicrobial brominated 2(5H)-
furanones that at appropriate concentrations are capable of 
controlling biofilm formation and virulence factors without 
the development of resistance. Moreover, it should be 
taken into account that a possible resistance to antibacterial 
brominated 2(5H)-furanone derivatives might be overcome 
by combining the administration of the antibacterial 
brominated furanones with that of efflux pump inhibitors 
[239,240].  
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We therefore believe that it is important to actively 
continue the studies on the synthesis and evaluation of the 
antimicrobial activity of brominated 2(5H)-furanone 
derivatives also including among these substances the 
following natural compounds for which synthetic methods 
have not yet been reported and the biological properties 
have not yet been evaluated: (Z,Z)-5,5’-(1,2-
dibromoethanediylidene)-bis(4-bromo-3-butyl)]-2(5H)-
furanone (417) [142], pulchralides A (418), B (419) and C 
(420), acetoxyfimbrolide C2 dimer (421), 
acetoxyfimbrolide meso dimer (422) [241], cis-4,11,12,13-
tetrabromo-3,10-dibutyl-1,6,8-
trioxadispiro[4.1.4.2]trideca-3,10,12-triene-2,9-dione (423) 
[142], and prunolides A (424) and B (425) [220] (Figure 
29]. 
 
 
 
Figure 29. Structures of naturally-occurring compounds 
419–427   
 
It is also our hope that the chemical and biological data 
reported in this review can be of help in designing efficient 
and versatile methods for the synthesis of these natural 
compounds and new, tunable, unnatural brominated 2(5H)-
furanone derivatives possessing interesting biological 
properties. 
 
LIST OF ABBREVIATIONS 
Ac = acetyl 
AHL = N-acyl homoserine lactone 
AIBN = 2,2’-azobisisobutyronitrile 
Ar = aryl 
BHL = N-butanoyl-L-homoserine lactone 
Bn = benzyl 
Bu = butyl 
coll = 2,4,6-trimethylpyridino 
Cp = cyclopentadienyl 
Cy = cyclohexyl 
d = day 
dba =  dibenzoylacetone 
DBU = 1,5-diazabicycloundec-7-ene 
DIBAH = diisopropylaluminum hydride 
DMF = N,N-dimethylformamide 
DMSO = dimethyl sulfoxide 
Et = ethyl 
Hept = heptyl 
Hex = hexyl 
HMPA = hexamethylphosphoramide 
IC50 = half maximal inhibitory concentration 
LDA  = lithium diisopropylamide 
MCPBA = m-chloroperbenzoic acid 
Me = methyl  
MIC = minimum inhibitory concentration 
MMPP = magnesium monoperoxyphthalate 
MW = microwave 
NAPDH = nicotinamide adenine dinucleotide phosphate 
NBS = N-bromosuccinimide 
NMP = N-methyl-2-pyrrolidone 
Oct = octyl 
PCC = pyridinium chlorochromate 
PDC = pyridinium dichromate 
Pent = pentyl 
Ph = phenyl 
Pr = propyl 
QQ = quorum quenching 
QS = quorum sensing 
rt = room temperature 
TBDMS = tert-butyldimethtylsilyl 
TFA = trifluoroacetic acid 
TFE = 2,2,2-trifluoroethanol 
THF = tetrahydrofurane 
TLC = tin-layer chromatography 
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TMS = trimethylsilyl 
Tol = tolyl 
p-Ts  = p-toluenesulfonyl 
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